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SUMMARY 
Despite the widespread interest in direct neuronal reprogramming, the mechanisms underpinning fate 
conversion remain largely unknown. Our study revealed a critical time point after which cells either 
successfully convert into neurons or succumb to cell death. Co-transduction with Bcl-2 greatly 
improved negotiation of this critical point by faster neuronal differentiation. Surprisingly, mutants with 
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reduced or no affinity for Bax demonstrated that Bcl-2 exerts this effect by an apoptosis-independent 
mechanism. Consistent with a caspase-independent role, ferroptosis inhibitors potently increased 
neuronal reprogramming by inhibiting lipid peroxidation occurring during fate conversion. Genome-
wide expression analysis confirmed that treatments promoting neuronal reprogramming elicit an anti-
oxidative stress response. Importantly, co-expression of Bcl-2 and anti-oxidative treatments lead to an 
unprecedented improvement in glial-to-neuron conversion after traumatic brain injury in vivo, 
underscoring the relevance of these pathways in cellular reprograming irrespective of cell type, in vitro 
and in vivo. 
 
 
INTRODUCTION 
Direct reprogramming of somatic cells has proven to be an extraordinary method to generate cell 
populations such as neurons that are otherwise difficult to obtain, for research purposes (Amamoto and 
Arlotta, 2014. In addition, replenishing neuronal populations in the injured brain using reprogramming-
based therapies is an exciting future prospect (Buffo et al., 2005; Heinrich et al., 2014). However, the 
cellular and molecular basis underlying direct reprogramming remains poorly understood. Most studies 
are restricted to the function of neurogenic reprogramming factors (Masserdotti et al., 2015; Ninkovic et 
al., 2013; Wapinski et al., 2013), while little is known about other aspects, such as metabolic changes or 
proliferation. As the function of neurogenic factors is context-dependent, this also prompts the question 
to which extent there may be mechanisms common to all cells types converting into neurons. For 
example, Neurogenin2 (Neurog2) efficiently induces neuronal conversion of mouse postnatal astrocytes 
in culture (Berninger et al., 2007; Blum et al., 2011; Heinrich et al., 2010) but is rather ineffective in 
mouse embryonic fibroblasts (MEFs) (Chanda et al., 2014) or adult reactive glial cells in vivo  (Grande 
et al., 2013). While the starting cell type may dictate conversion efficiency by providing transcriptional 
accessibility of target genes (Wapinski et al., 2013), other cellular processes shown to influence 
reprogramming into induced pluripotent stem cells (iPSCs) such as cell death (Kawamura et al., 2009), 
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proliferation rate (Halley-Stott et al., 2014; Ruiz et al., 2011) or metabolic state (Zhang et al., 2012), 
may also be important in direct neuronal reprogramming. Among them, the metabolic state is 
particularly relevant for the conversion into neurons, which rely on oxidative metabolism, while 
astroglia, fibroblasts and proliferative cells rather utilize anaerobic glycolysis and β-oxidation (McKay 
et al., 1983; Tsacopoulos and Magistretti, 1996). Moreover, metabolic factors such as reactive oxygen 
species (ROS) have been implicated in cell fate regulation (Maryanovich and Gross, 2013). Here, we 
used continuous single cell live imaging to monitor direct reprogramming of fibroblasts and glia into 
neurons. We identify stage specific barriers and metabolic regulators increasing conversion efficiency 
both in vitro and in vivo. 
  
RESULTS 
A Critical Checkpoint Eliciting Cell Death in Neuronal Conversion  
To target also postmitotic cells, we transfected astroglial cells isolated from mouse cerebral cortex at 
postnatal day (P) 5-7 with a dual red fluorescent protein (RFP) and Ascl1-encoding vector (Heinrich et 
al., 2010; Masserdotti et al., 2015) and tracked RFP+ cells starting at 26-29 hours after transfection 
(Figure 1A). In this model, neuronal conversion is achieved within 7 days, and can be monitored by 
continuous single cell imaging. Images were taken every 5 minutes in phase contrast and 5 hours in the 
fluorescence channel (RFP+; Movie S1; Figure 1B shows stills from such movies). To follow the fate 
conversion we used 3 methods: neuronal morphology (Movie S1, Figure 1B-H and Figure S1A), GFP 
driven by the Doublecortin promoter (DCX-GFP; Movie S2, Figure S2A-C), and immunostaining for 
neuron-specific antigens (Figure S2D, E). The first signs of neuronal conversion were visible by weak 
DCX-GFP signals at around 24 hours of live imaging (Figure S2A1, B1, H-blue line; i.e. about 2 days 
after transfection, see Figure 1A) and most cells that became DCX-GFP+ did so within the first 2 days 
of imaging (Figure S2A1, B1, C-blue line), i.e. about 3 days after transfection (Figure 1A). Thus, the 
regulation of key neuronal genes occurs rapidly and is implemented within few days (see also 
(Masserdotti et al., 2015)). Within 50 hours of imaging, i.e. about 3 days after transfection, the first 
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Ascl1/RFP+ cells changed from flat astrocyte to neuronal morphology (Figure 1B1, C1). Noteworthy, 
more than 90% of cells classified with a neuronal morphology were accordingly immuno-reactive for 
β-III-tubulin and MAP2. The more mature neuronal marker NeuN was present in only in 60% of cells 
with neuronal morphology (Fig. S1B, C). Among the cells with non-neuronal morphology we found 
cells in fate transition immunoreactive for both neuronal (β-III-tubulin) and astroglia (GFAP) markers 
(Figure S1E, upper panels). Cells with a neuronal morphology were never found to be double-positive 
for GFAP and neuronal markers (Figure S1E, lower panels), confirming the stringency of these criteria.   
By about 150 hours of imaging (7 days post-transfection, DPT) most RFP+ cells had developed a 
neuronal morphology (Figure 1B1, C1 and D, left bars) or DCX-reporter activity (see example in 
Figure S2A1, B1, C-blue line). However, at that time the number of RFP+ cells had decreased 
dramatically, with only about 18% of all RFP+ cells observed at the beginning of the time lapse (see 
Movie S1) surviving to the end (Figure 1B1, C1, D, left bars). The peak of cell death occurred between 
50-100 hours imaging (Figure 1B1, C1, D, left bars), when fate conversion manifests by morphological 
changes (Figure 1B1, C1). Most (94%) transfected cells that did not acquire a neuronal morphology 
underwent cell death at some point during the observation period (Figure 1D, G, left bars), while only 
48% of the cells with neuronal morphology died (Figure 1H, left bar). Accordingly, most cells 
surviving until the end of imaging were reprogrammed into neurons (Figure 1B1, C1, D, left bars; 
Figure S2A1, B1, C-blue line). Thus, cell death is a main limiting factor of neuronal reprogramming 
and peaks at the time of fate conversion. Conversely, proliferation is limited in this paradigm (Figure 
1F, left bar) with most astrocytes directly converting into neurons (Figure 1C1). 
 
Bcl-2 improves fate conversion and survival 
To improve survival during reprogramming, we first examined the effect of the anti-apoptotic protein 
Bcl-2. Indeed, co-expression of Bcl-2 with Ascl1/RFP in astrocytes not only increased the total number 
of surviving cells, but also the number of induced neurons (iN), based on morphological analysis 
(Figure 1B-D), DCX-reporter activity (Figure S2A-C) and immunostaining for β-III-tubulin and MAP2 
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at 5 days DPT (Figure S2D, E). Furthermore, continuous single cell imaging revealed a faster 
conversion of Ascl1/Bcl-2 co-transfected astrocytes, with a significant increase in the proportion of 
cells with neuronal morphology in the initial phases (8-fold at 50h of tracking time; Movie S1, Figure 
1C-E) and faster acquisition of DCX-reporter (Movie S2, Figure S2A-C) but no effect on cell 
proliferation (Figure 1F). Bcl-2 expression increased the proportion of surviving cells in the whole 
transfected population (Figure 1B-D; Figure S2A-C), while each class of cells, i.e. those with neuronal 
and non-neuronal morphology, still died as much as cells not co-expressing Bcl-2 (Figure 1G, H). 
Thus, the main effect of Bcl-2 is to facilitate fate transition from astrocytes to neurons, which then have 
a lower death rate (Fig. 1I).  Bcl-2.  
Continuous live imaging results were further corroborated by immunostaining and electrophysiology. 
Indeed, neuronal morphology faster acquired by Bcl-2 co-expression correlated with lower resting 
membrane potential (RMP=-60 to -40 mV; Figure S2F, G) typical for immature neurons (Pedroni et 
al., 2014), while astrocytes have a RMP of -90 to -80 mV (Anderova et al., 2004) (Figure S2F, G). 
Notably, at 5DPT, when most reprogrammed cells have already acquired DCX-GFP, β-III-tubulin, 
MAP2 and NeuN expression (Figure S1C, D), their electrophysiological properties are still immature 
and only 10% of Ascl1/Bcl-2 co-transfected cells exhibited some very immature action potential-like 
features (Figure S2F3). However, iNs recorded at 15 DPT showed action potentials consistent with 
fully developed neurons (Figure S2H).  Taken together, these results demonstrate that Bcl-2 improves 
reprogramming by faster fate conversion.  
 
Bcl-2 Promotes the Efficiency of Neuronal Conversion Via a Non-Canonical Pathway  
As the Bcl-2 effect seems not only related to its anti-apoptotic role, we examined the contribution of its 
canonical function via the interaction with the pro-apoptotic Bax/Bak. Bcl-2 inhibits apoptosis by 
sequestering Bax/Bak when phosphorylated at serine 69/70 (Deng et al., 2006) (Figure 2A). The 
replacement of both Ser69/70 by glutamic acid (EE-Bcl-2) mimics the constitutively phosphorylated 
form of Bcl-2, that sequesters Bax (Figure 2A), while substitution of Ser70 by alanine (A(70)-Bcl-2; 
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Figure 2A) mimics the un-phosphorylated form of Bcl-2, reducing the binding to Bax (Deng et al., 
2006). Likewise, A(145)-Bcl-2 is unable to bind Bax due to a Glycine145/alanine substitution (Figure 
2A; Yin et al., 1994).  
Co-expression of EE-Bcl-2 increased survival of cells transfected with Ascl1 (Figure 2B), but did not 
alter the proportion of iNs (blue bars in Figure 2C). As expected, A(145)-Bcl-2 had no significant 
effect in promoting cell survival during reprogramming (Figure 2B), but surprisingly still increased the 
proportion of Ascl1-transfected cells that turned into neurons (blue bars in Figure 2C). Co-transduction 
with A(70)-Bcl-2 still retained some effect on cell survival (comparable to WT-Bcl-2, Figure 2B) and 
was most efficient in neuronal conversion, due to the added effect of rescuing non-converted cells from 
death and allowing them to convert more efficiently (Figure 2C, grey and blue bars respectively). 
Moreover, we also observed increased length and complexity of the neuronal processes in cultures co-
transfected with wild type (WT)-Bcl-2, A(70)-Bcl-2 or A(145)-Bcl-2 but not with EE-Bcl-2 (Figure 
2D), further supporting an additional non-apoptotic role of Bcl-2 in neuronal reprogramming. 
Importantly, Bcl-2 also enhanced conversion efficiency obtained from astrocytes transduced with 
Neurog2 (Figure 2E), which induced mature glutamatergic neurons (vGlut1+ cells, Figure 2F). Both 
WT-Bcl-2 and, to a greater extent, A(70)-Bcl-2 potently enhanced reprogramming of mouse embryonic 
fibroblasts (MEFs) in combination with a single neurogenic fate determinant  (Ascl1, Figure 2H, I and 
Figure S3A, C; Neurog2, Figure S3B, E, F) givig rise to functional neurons able to fire action 
potentials (Figure S3D). Notably, Bcl-XL, a member of the Bcl-2 family, had a similar effect on 
reprogramming as WT-Bcl-2 (data not shown). However, in the absence of a neurogenic factor neither 
A(70)-Bcl-2 nor any other Bcl-2 construct nor Bcl-XL alone were able to induce neuronal conversion 
(Figure 2G and Figure S3C and data not shown). We thus conclude that Bcl-2-related proteins act as a 
potent facilitators of direct neuronal reprogramming for different transcription factors in different cell 
types and does so most potently in the A(70)-Bcl-2 mutant form. 
  
Mode of Cell Death in Neuronal Reprogramming 
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As EE-Bcl-2, the mutant which exhibits an improved anti-apoptotic function, increases cell survival 
but does not improve the proportion of iNs, we tested how different modes of cell death affect neuron 
numbers. The pan-caspase/apoptosis inhibitor Z-VAD-FMK (ZVAD, 20 µM) was added once at day 2 
to Ascl1-transfected astrocytes, resulting in a significant increase in surviving cells (Figure 3A) without 
affecting the proportion of iNs neither amongst the initially transfected cells (Figure 3B, grey bars) nor 
at the end point (Figure 3B, blue bars). Thus, like EE-Bcl-2, blocking caspase activation does not 
improve neuronal conversion. We then tested the effects of RIP-K dependent necroptosis and the 
oxidative stress-dependent ferroptosis (Dixon et al., 2012) by using their respective inhibitors 
Necrostatin-1 (Degterev et al., 2005) and Liproxstatin-1 (Friedmann Angeli et al., 2014). While 
Necrostatin-1 had similar effects to ZVAD in rescuing some cells from death (Figure 3A), but no 
effects on iNs (Figure 3B), Liproxstatin-1 had a potent effect on conversion efficiency (Figure 3B). 
Thus, while apoptosis and necroptosis inhibitors protect cells from death, only the ferroptosis inhibitor 
liproxstatin-1 promotes both survival and neuronal conversion.  
 
Increased Lipid Peroxidation During Neuronal Reprogramming 
Given the positive effects of Liproxstatin-1 treatment on reprogramming efficiency, we next examined 
lipid peroxidation (Lip-Ox) as a hallmark of ferroptosis (Dixon et al., 2012) by using two different 
reporters: Click-iT lipid peroxidation kit based on linoleamide alkyne (LAA) reagent (Life 
technologies) and C11-Bodipy (Drummen et al., 2002). Astrocyte cultures treated with cumene 
hydroperoxide as a positive control for Lip-Ox had increased signal from the LAA-based reporter in 
almost all cells (Figure 3C, upper row). Without any additional treatment, 60% of Ascl1-transfected 
cells exhibited the signal for Lip-Ox at 3 DPT, in contrast to 25% of cells transfected with the control 
plasmid (Figure 3C, D), suggesting that Lip-Ox occurs primarily during neuronal reprogramming. 
Similar results were obtained with C11-Bodipy, which integrates into phospholipid-containing 
membranes and shifts from red to green fluorescence upon oxidation (Drummen et al., 2002). We also 
tested -Tocopherol (Toc, one of the forms of Vitamin E, 20µM), known to protect against Lip-Ox 
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(Buettner, 1993), and found that it strongly reduces Lip-Ox LAA-signal in astrocytes undergoing 
neuronal conversion (Figure 3C, D).  
Given the non-canonical effect of Bcl-2 on neuronal reprogramming, we examined its effect on Lip-
Ox. Indeed, all forms of Bcl-2 significantly reduced Lip-Ox with EE-Bcl-2 being the weakest and 
A(70)-Bcl-2 the strongest (Figure 3D). This result was observed with both reporters (Figure 3D, E), 
demonstrating a novel role of Bcl-2 in protecting from Lip-Ox most potently in the A(70)-Bcl2 mutant 
form. Consequently, we hypothesized that any condition that reduces Lip-Ox should be beneficial for 
direct neuronal reprogramming. Indeed, Toc treatment, almost doubled the proportion of Ascl1/RFP 
reprogrammed neurons obtained from astrocytes at 5DPT (Figure 4A-C) and improved conversion 
efficiency of cells co-treated with ZVAD or co-expressing Ascl1/EE-Bcl-2 (Figure 4A, B). Thus, the 
anti-oxidant Vitamin E improves direct neuronal reprogramming. 
   
Forskolin Promotes the Efficiency of Neuronal Conversion and Reduces Lipid Peroxidation 
We next tested if other molecules known to improve reprogramming such as Forskolin (Fk; Liu et al., 
2013a) may also alleviate Lip-Ox. First we verified its positive effects on reprogramming in astrocytes 
aiming to determine if it would act similarly from what we had observed with Bcl-2. Both in 
continuous live imaging (Figure S4A-D) and after immunostaining at 5DPT (Figure 4D, E) we 
observed more cells surviving and efficiently converting after addition of 20µM forskolin to Ascl1-
transfected astrocyte cultures. As for Bcl-2, we also observed a faster conversion (Figure S4A-D) 
without any effect on proliferation (Figure S4E). This effect is both transcription factor and cell type 
independent, as Fk also improved reprogramming efficiency of MEFs and pericytes (Figure S5) 
mediated by different transcription factors (i.e, Ascl1, Neurog2, Sox2) but did not induce neuronal 
conversion in absence of any neurogenic fate determinant (Figure S4F and S5C). 
As expected, the proportion of Lip-Ox reporter-positive cells among Ascl1-transduced astrocytes was 
significantly reduced from about 60% to below 20% by Fk treatment (Figure 4F, G). Likewise, 
CellRox Green reagent (Molecular probes; Figure 4H) showed high levels of nuclear green 
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fluorescence in Ascl1 transduced astrocytes at 3DPT, when many cells succumb to cell death, which 
was reduced after Fk treatment (Figure 4H). As further proof of oxidation-dependent processes 
occurring during reprogramming, we monitored the oxidation of peroxiredoxin-2, a protein involved in 
oxidative stress detoxification (Prx2; Godoy et al., 2011), by Western Blot. Prx2 was predominantly 
detected in its dimeric (oxidized) form in astrocytes and MEFs 3 days after transduction with Ascl1, 
and dimerization was reduced by Fk treatment (Figure 4I). Thus, reducing oxidative stress during 
reprogramming facilitates neuronal conversion. 
 
Genome-Wide Expression Analysis Reveals Anti-Oxidative Stress Response in Improved 
Neuronal Reprogramming  
To identify candidate genes regulated by non-canonical Bcl-2 function and by Fk treatment that may 
promote neuronal conversion, we collected mRNA from different batches of MEF cultures. These were 
transduced with Ascl1/RFP- or RFP-encoding vectors and treated or untreated with Fk for 24 hours 
(1DPT) or co-transduced with A(70)-Bcl-2-GFP (Figure 5A). Upon Fk treatment 507 probe-sets were 
significantly regulated (p˂0.01, fold change ≥1.5x, see Table S1; for genes regulated after A(70)-Bcl-2 
co-transduction see Table S2). Heat maps show the 60 strongest up-regulated genes upon Fk treatment 
of Ascl1 transduced cells (Figure 5B, left panel) and the subset of transcriptional regulators (right 
panel). The reliability of the transcriptome analysis was confirmed by quantitative real-time PCR 
analysis (Figure 5C). As expected from the known role of Fk we found increased expression of genes 
involved in the cAMP signalling-pathway (Table S3) and many targets of Creb, including those 
regulating neurite outgrowth and cAMP-signalling mediators (Tables S1, S3), as well as genes 
promoting neuronal differentiation (e.g. Prox1, Eya2, Sox11; Figure 5B). In addition, we found 
enrichment of several signalling pathways (e.g. IL-10 & Il-1; Wnt, Bmp) and nuclear receptors (Figure 
5B and Table S3). Interestingly, some of these genes, including Nrf-2 effectors and JAK/STAT (Table 
S1, S3) are known to regulate metabolism and the oxidative stress response (Nguyen et al., 2009; Park 
et al., 2012). GO term analysis further supported anti-oxidative pathways activated by Fk, with  Nrf2-
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mediated pathway at the top (Table S3). Indeed, we confirmed increased Nrf2 responsive luciferase 
activity 15h after Fk addition (Figure 5D). Interestingly, Nrf2-mediated pathway was found activated 
by both Fk treatment and A(70)-Bcl-2 co-expression (Table S4). These data support the notion of 
excessive oxidation occurring during reprogramming and Fk as well as A(70)-Bcl-2 alleviating this.   
As Vitamin D receptor (Vdr) was already implicated in the anti-oxidative stress response (Bao et al., 
2008; Dong et al., 2012), we validated its up-regulation at mRNA level in MEFs and astrocytes (Figure 
5E; see also confirmation of other nuclear receptors) and protein level in astrocytes (Figure 5F). We 
then tested its effect on Lip-Ox in astrocytes and found that co-expression of Vdr reduced the 
percentage of cells positive for LAA-based reporter to less than 1/3 in Ascl1-transfected astrocytes at 
3.5 DPT (Figure 5G). Accordingly, co-transfection with Vdr improved neuronal reprogramming by 
Ascl1 or Neurog2 to a similar extent as Fk (data not shown) or Bcl-2 co-transfection (Figure 5H-K). 
Co-transduction of Bcl-2 and Vdr further increased reprogramming (Figure 5H-K) reaching up to 80% 
neurons amongst Ascl1-transduced astrocytes (Figure 5H, J). Taken together, genome-wide expression 
analysis confirmed the key role of oxidative stress response in regulating reprogramming, with Vdr as 
the top transcriptional regulator. 
 
The Role of Bcl-2 and Anti-Oxidants in Neuronal Reprogramming In Vivo  
We next examined the relevance of the above identified pathways after brain injury in vivo. Such 
lesions induce a highly inflammatory environment (Abdul-Muneer et al., 2014) that may impose 
oxidative stress and other metabolic constrains to the generation and survival of iNs. Indeed, in the 
intact striatum and cerebral cortex neuronal reprogramming was more efficient (Guo et al., 2014; Niu 
et al., 2013; Torper et al., 2013) than after large invasive brain injury (Grande et al., 2013; Heinrich et 
al., 2014). Among the previously tested factors we chose Neurog2, as it instructs glutamatergic neurons 
in the developing cerebral cortex (Imayoshi and Kageyama, 2014) from astrocytes in vitro (Berninger 
et al., 2007; Heinrich et al., 2010; Masserdotti et al., 2015), but exhibits a limited efficiency in neuronal 
conversion after brain injury in vivo (Grande et al., 2013).  
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Retroviral vectors encoding Neurog2-IRES-RFP alone or in combination with Bcl-2-IRES-GFP were 
injected close to the stab-wound injury site 3 days later (Figure 6A) as previously described (Buffo et 
al., 2005; Heinrich et al., 2014) and immunohistochemistry was performed at 10 days post-injection 
(DPI). GFP or Bcl-2 single (GFP+) infected cells were NG2+ glia or S100/GFAP+ astrocytes (Figure 
6C and S6C). Similarly, most of the cells transduced with Neurog-2 (RFP+ only) were glia and only 
rarely acquired the neuronal marker NeuN (Figure 6B, C, F; 2% in only Neurog2 infected brains, 
Figure S6D). Conversely, many co-transduced cells (GFP+/RFP+) exhibited elongated neuronal-like 
morphology and were immuno-reactive for DCX or NeuN (Figure S6E, Figure 6C). Indeed, around 
75% of co-transduced cells had turned into NeuN+ neurons with a clear neuronal morphology at 10 
DPI (Figure 6F). Taken together, addition of Bcl-2 not only increased the number of NeuN+ iNs but 
also accelerated neuronal maturation, as appearance of NeuN typically takes about 14-21 DPI (Grande 
et al., 2013). Thus, as in vitro, Bcl-2 potently improves reprogramming speed and efficiency in vivo.   
We next examined whether activating the Vdr pathway by the ligand calcitriol after Neurog2/RFP 
transduction with/without Bcl-2/GFP would elicit a further improvement in reprogramming. Strikingly, 
a single calcitriol administration at 2 DPI more than doubled the proportion of NeuN+ iNs in Neurog2 
transduced cells (Figure 6D, F; 3.5-fold increase in only Neurog2 infected brains, see Figure S6D). 
Most importantly, calcitriol treatment resulted in almost 90% conversion of all Neurog2/Bcl-2 co-
transduced cells (GFP+/RFP+; Figure 6D, F), dramatically increased levels of NeuN (see Figure S6F, 
G) and improved morphology and complexity of iNs, resulting in the formation of long neuronal 
processes (Figure S6G). Moreover, long-term analysis of iNs after calcitriol treatment often revealed 
very elaborate neurites with bouton- (20 DPI, Figure 6G) and/or spine-like structures (60 DPI, Figure 
6H). Taken together, these data demonstrate that calcitriol has a beneficial effect on the reprogramming 
efficiency but more importantly, on the maturation of iNs.  
To confirm that the oxidative state directly affects reprogramming in vivo, we administered -
Tocotrienol (T3; Figure 6A), the vitamin E analogue described above. Similarly to calcitriol, T3 
administration improved the conversion efficiency and the levels of NeuN (Figure 6E, F). Strikingly, 
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cells co-transduced with Neurog2/Bcl-2 displayed a very complex neuronal morphology in animals 
treated with T3 already at 10 DPI (Figure 6E and 7A) and had a soma size comparable to the 
endogenous neurons in the same area (Figure 7A, B). Notably, iNs also reached this soma size after 
calcitriol administration, but at a much later time points (60 DPI, see Figure S6H and 7A). Likewise, 
upon T3 treatment iNs exhibited the first spine-like protrusions already at 10 DPI (Figure 7A, left 
panels), further corroborating the faster iN differentiation and maturation elicited by this anti-oxidant.  
As Neurog2/Bcl-2 over-expression and T3 administration resulted in most developed iNs, we used 
this paradigm to determine their subtype identity. Regardless of the localisation of the co-transduced 
cells, about 80% were immunopositive for Ctip2 (Figure 7D, G), a marker for layer 5 subcortical 
neurons (Arlotta et al., 2005; Molyneaux et al., 2007). Most of the remainder (20%) were positive for 
the deep layer marker FoxP2, albeit with lower intensity than endogenous neurons (Figure 7C, G; 
Molyneaux et al., 2007). Consistent with a layer 5 pyramidal neuron identity, iNs were negative for the 
upper layer markers Satb2 (Figure 7F left panels, G; Britanova et al., 2008) or Cux1 (Figure 7F right 
panels,G;  Nieto et al., 2004) and the interneuron transmitter GABA (Figure 7E). Therefore, we 
confirmed the identity of reprogrammed cells as deep layer glutamatergic pyramidal neurons, 
consistent with the role of Neurog2 in cortical development (Schuurmans et al., 2004). 
 
DISCUSSION 
Here we used continuous live imaging to unravel critical hurdles in direct neuronal reprogramming. 
Neuronal conversion became detectable around 2-4 days after transduction by live neuronal (DCX-
GFP) reporters, post-imaging immunostaining (-III-tubulin, MAP2, NeuN) and morphological 
analysis (small cell soma and thin processes). At around the same time, most transduced astrocytes 
succumbed to cell death, while fewer of the successfully converted cells died, suggesting that high 
levels of Ascl1 may be incompatible with astrocyte survival under these conditions. Importantly, few 
astrocytes proliferated – neither prior to cell death nor prior to fate conversion. Thus, a major limitation 
in reprogramming efficiency is cell death around the time of fate conversion.   
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Different Modes of Cell Death and Oxidative Stress Limit Neuronal Reprogramming 
While blocking apoptosis by caspase inhibitors and necroptosis by RIPK1 inhibitors significantly 
increased cell survival, these cell death pathways did not affect the proportion of iNs. This revealed an 
additional block for neuronal conversion that could be consistently relieved by ferroptosis inhibitors 
(Liproxstatin-1 or Vitamin E). Ferroptosis is typically induced by ROS resulting in peroxidation of 
lipids due to impaired cysteine availability, glutathione depletion and GPX4 inhibition (Dixon et al., 
2012; Friedmann Angeli et al., 2014; Yang et al., 2014). Hence, excessive ROS may be generated as a 
consequence of instructing reprogramming per se or specifically into neurons, that use oxidative 
phosphorylation. In favour of the former possibility are the findings of an oxidative burst with 
deleterious consequences during the generation of mouse iPSCs (Kida et al., 2015; Qi et al., 2015), 
initiated when cells are instructed to divide fast during reprogramming (Kida et al., 2015). This is 
notably different from direct neuronal reprogramming, where few cells divide and yet increased ROS 
and Lip-Ox occur. We therefore favour the hypothesis that this effect is due to transitioning too hastily 
to the neuronal oxidative metabolism during reprogramming (see also below). 
Consistent with high oxidation levels limiting neuronal reprogramming efficiency, we show here that 
treatments beneficial for reprogramming, such as Fk or A(70)-Bcl-2, reduce Lip-Ox and mount an anti-
oxidative response mediated by Nrf2 amongst others. Various agents attenuating Lip-Ox, such as 
Toc, T3 or Calcitriol, also improve neuronal reprogramming. This is not only of crucial importance 
to better understand the conversion process into iNs but also for the wide-spread application of 
generating neurons from different cell types (astrocytes, MEFs, pericytes etc.) with various neurogenic 
transcription factors (Ascl1, NeuroD4, Neurog2, Sox2 etc) at much increased efficiency.    
 
An Un-expected Role for Bcl-2 In Direct Neuronal Reprogramming 
Interestingly, Bcl-2 affected both reprogramming efficiency and speed of neuronal conversion in a 
manner un-coupled from its function in apoptosis. The Bcl-2 mutant with increased affinity for 
 15 
Bax/Bak and therefore improved anti-apoptotic function (EE-Bcl-2) neither improved neuronal 
reprogramming nor reduced Lip-Ox. In contrast, A(145) and A(70)-Bcl-2 mutants, unable to bind 
Bax/Bak and with reduced anti-apoptotic function (Deng et al., 2006; Yin et al., 1994)  improved 
neuronal reprogramming, with the latter being the most effective in reducing Lip-Ox and, 
consequently, enhancing reprogramming efficiency. While this is the first time that specific Bcl-2 
mutants have been used to assess selective effects on Lip-Ox, Bcl-2 has formerly been implicated in 
the regulation of both metabolic transition and oxidative stress pathways, by reducing oxidation in 
mitochondria (Krishna et al., 2011) or improving metabolic conversion via interaction with e.g. p53 or 
Myc (Deng et al., 2006; Jin et al., 2006). As EE-Bcl-2 interacts strongly with Bax, its lack of effect on 
reprogramming could be due to its reduced availability for molecular partners acting in the nucleus. 
Conversely, A(70)-Bcl-2 may be more efficient in improving neuronal reprogramming as more of this 
protein may be available in the nucleus for interaction with relevant partners.  
Notably we show that Fk and A(70)-Bcl-2 lead to common transcriptional changes in pathways (e.g. 
LXR) that have been previously implicated in neurogenesis (Theofilopoulos et al., 2013), suggesting 
that nuclear interactions of Bcl-2 may explain the particular efficiency of the A(70)-Bcl-2 mutant in 
direct neuronal reprogramming. Although not precluding additional roles of Bcl-2 at the mitochondria 
or other mechanisms, our data demonstrate that the effect of Bcl-2 in reprogramming is independent of 
its well-known anti-apoptotic function. 
 
Metabolic Conversion as Critical Factor in Direct Neuronal Reprogramming 
Importantly, factors alleviating Lip-Ox also accelerate fate transition. We observed this in vivo and by 
continuous single cell tracking analysis in vitro, both upon Fk treatment and in cells co-expressing Bcl-
2 (Figure 1 and Figure S3). Fk treatment regulates several genes affecting the cellular redox potential, 
e.g. Nor-1 that promotes the endurance phenotype in oxidative muscle fibers (Pearen et al., 2012) and 
Vdr that alleviates oxidative stress in various organs (Dong et al., 2012; George et al., 2012). It has 
been previously shown that ROS and redox-signaling mechanisms play a key role in cell fate decisions 
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including neurogenesis (Maryanovich and Gross, 2013; Prozorovski et al., 2015), although the 
molecular mechanisms mediating these effects are not yet fully understood. In iPSC reprogramming, 
changes to a more glycolytic metabolism have been shown to govern fate conversion (Liu et al., 
2013b), despite the initial oxidative burst mentioned above (Kida et al., 2015). The faster neuronal 
conversion when excessive oxidation products are successfully controlled is consistent with a) ROS 
affecting gene expression, e. g. by altering SIRT activity, a key regulator of neurogenesis and b) 
interfering with metabolic pathways acting up-stream of other aspects of fate conversion. If the 
metabolic transition is a pre-requisite for the conversion in cell fate, redox homeostasis failure may 
ultimately reduce efficiency or speed of conversion.  
Confirming this hypothesis, we observed that cells cultured in a medium with oligomycin A, allowing 
anaerobic glycolysis as the only metabolic pathway to generate ATP (see Suppl. Material), preserved 
astroglial features and interfered with the conversion to a neuronal fate (Figure S7A-C,E-F). As the 
total cell number did not decrease much (Figure S7A, F), fate conversion seems to be blocked when 
oxidative phosphorylation is hampered. Notably, cells grown in anaerobic glycolysis-only medium 
were also protected from Lip-Ox (Figure S7C, D), demonstrating that the metabolic change during 
neuronal reprogramming causes oxidative stress. Conversely, boosting the metabolic shift with a 
medium containing 2-deoxy-glucose, which can only be metabolized at mitochondria (see Suppl. 
Material), caused extraordinarily high levels of Lip-Ox (Figure S7C) in astrocytes and resulted in cell 
death (Figure S7A, F). Overall, these experiments demonstrate that the metabolic shift is not only 
necessary to allow survival of the neurons during reprogramming but also constitutes a pre-requisite 
for cell fate transition. 
 
Potent Improvement of Direct Reprogramming in the Injured Brain In Vivo 
Importantly, T3 supplementation or activation of anti-oxidant pathways by calcitriol was remarkably 
powerful in improving iN maturation from reactive glia after traumatic brain injury in vivo. 
Interestingly, calcitriol treatment has been shown to reduce glutamate-induced neuronal death in vitro 
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and attenuate hypoxic brain damage in vivo (Gianforcaro and Hamadeh, 2014), as well as the fibrotic 
reaction upon injury in other organs (Ding et al., 2013; Sherman et al., 2014). These data thus suggest 
that calcitriol alleviates several negative effects after injury. While both calcitriol and T3 also 
improve efficiency of reprogramming but predominantly affect maturation and neurite growth, Bcl-2 
co-expression was the most efficient in increasing iNs. The combined action of Bcl-2 and Calcitriol or 
T3 allowed us for the first time to achieve an in vivo reprogramming efficiency of more than 90% 
after stab wound injury. The neurons survived for several months and acquired a remarkably advanced 
state of maturation. These data demonstrate that the number of neurogenic fate determinants was not 
the limiting factor in neuronal reprogramming after injury in vivo, as believed so far. In fact, while 
applying various combinations of neurogenic transcription factors only marginally improved 
reprogramming in the same paradigm (Buffo et al., 2005; Grande et al., 2013; Heinrich et al., 2014; 
Kronenberg et al., 2010), co-expressing Bcl-2 and alleviating excessive ROS had an astounding effect. 
Indeed, our protocol allowed iNs to proceed largely to a specific neuronal subtype, namely Ctip2+ 
pyramidal neurons even when they were located at more superficial positions and surrounded by 
Cux1+ upper layer neurons. Interestingly, Ctip2 is not a direct target of Neurog2 (Masserdotti et al., 
2015; Schuurmans et al., 2004) and acts as the key effector of subcortical deep layer neuron fate 
(Amamoto and Arlotta, 2014). Moreover, Neurog2 knock-out mice have selective defects in deep 
layer, but not upper layer neurons of the developing cerebral cortex (Fode et al., 2000) supporting the 
concept that Neurog2 is largely involved in specifying deep layer neuron fate in this region.   
Taken together, our data on the mechanisms facilitating the metabolic transition and redox homeostasis 
in neuronal reprogramming have not only wide-spread relevance for brain injury and repair, but also 
highlight the urgency of improving the timely and coordinated metabolic conversion as well as 
protection from ferroptosis in aiming at neuronal repair.  
 
EXPERIMENTAL PROCEDURE 
Primary Cell Cultures  
 18 
Astrocytes were cultured and transduced as described in Heinrich et al. (2010) and MEFs as 
described in Vierbuchen et al. (2010). 
Live Imaging Microscopy 
Time-lapse video microscopy was performed with a cell observer (Zeiss) at a constant 
temperature of 37Cº and 8% CO2. Phase contrast images were acquired every 5 minutes, and 
fluorescence pictures every 4-6 hours for 6.5-7.5 days using a 10x phase contrast objective 
(Zeiss), and an AxioCam HRm camera with a self-written VBA module remote controlling Zeiss 
AxioVision 4.7 software. Movies were assembled and analyzed using ImageJ (National Institute 
of Health, USA) software. For description of the analysis see supplementary procedures section. 
Analysis of Lipid Peroxidation 
For the detection of lipid peroxidation we used either the reagent Click-iT lipid peroxidation kit 
based on linoleamide alkyne (LAA) reagent (Life Technologies) or BODIPY® 581⁄591 C11 
(C11-Bodipy, Molecular Probes; Drummen et al., 2002). Astroglial cells were first cultured and 
transfected as previously described (Heinrich et al., 2010; see also supplementary information). 
3,5 days later the cells were labelled according to the specifications described in the product data 
sheet and fixed with 4% paraformaldehyde (PFA) for 5 minutes. Finally, the direct fluorescence 
of the reporters was detected by epi-florescent microscopy.   
Animal Surgery 
Operations were performed in accordance with the policies of the state of Bavaria under license 
number 55.2-1-54-2532-171-2011. Three days after performing a stab-wound injury (Sirko et al. 
2013; Simon et al. 2011), 0.5-1 μl of retroviral suspension (Neurog2-IRES-RFP alone or 1:1 with 
Bcl-2-IRES-GFP) was injected into the site of the lesion as described by Heinrich et al., 2014. 
When indicated in the text, 200 μl of Calcitriol (1 ng/μl, Tocris) or T3 (100 mg/kg body weight, 
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Sigma Aldrich) diluted in corn oil were administered through oral gavage at 2 DPI. The dosage 
was determined according with previous publications (Park et al., 2011; Nashold et al. 2013). 
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FIGURE LEGENDS 
Figure 1. Time-lapse Analysis of Astrocyte-to-Neuron Reprogramming. 
(A) Schematic of the experimental protocol used for time-lapse video analysis.  
(B) Still images from video-time lapse movies (see Movie S1) showing cells classified as non-
neuronal/astroglial (green arrows), neuronal (yellow arrows) and dying (red arrows) at the time in vitro 
indicated transfected with the constructs indicated.  
(C) Progeny-trees of single cells tracked from example in B showing astrocytes (green lines) dead cells 
(depicted with “x”) and neurons (yellow lines).  
(D-H) Histograms depicting cell survival and neuronal conversion from movies (N=5 for control; 339 
cells tracked; N=4 with Bcl-2, 237 cells tracked) based on morphological classification as detailed and 
verified by immunostaining in Figure S1A-D. The percentage of neurons is normalized to the initial 
number of transfected cells in D, E.  
(I) Schematic summary of reprogramming and cell death as indicated by gradients of the respective 
colour.  
Error bars indicate ±SD. **p˂0.01, ***p˂0.001, p≥0.05 no statistically significant difference (n.s.); 
ANOVA Tukey’s post-hoc test in D; t test in E, F, G, H. Scale bars 40 μm. 
See also Figure S1 and Movies S1/S2. 
 
Figure 2. Non-canonical, BAX-independent Effect of Bcl-2 on Neuronal Reprogramming.  
(A) Cartoon depicting previously described interactions of Bcl-2 with several molecular partners as 
described in the text.  
(B, C) Histograms (with corresponding micrographs showing immunostaining for β-III-tubulin, in D) 
depicting the survival and fate conversion rate at 5DPT (for details see supplementary material) in 
astroglial cultures transfected with the constructs indicated (N=3; cells=900-2500 for each condition).  
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(E, I) Histograms showing the proportion of β-III-tubulin+ neurons at 7 days after transduction of 
astrocytes with a viral vector containing Neurog2 alone or with Bcl-2 (E, N=3; cells=1500-2000 for 
each condition) or 15 DPI of MEFs with the vector indicated (I, N=3; Cells=340-700 for each 
condition).  
(F) Confocal micrographs showing that iNs from E are immuno-reactive for vGluT1 at 15 DPI. 
(G) Arrows indicate astrocytes co-transfected with Bcl-2 and RFP (Red cells) being immuno-positive 
for GFAP (green) and retaining astroglial morphology at 7 DPT. 
(H) Micrographs of fibroblast conversion into neurons (β-III-tubulin+ cells; green) at 15 DPI upon 
transduction with retroviral vectors of the constructs indicated.  
Error bars indicate ±SD. *p˂0.05, **p˂0.01, ***p˂0.001; ANOVA with Tukey’s post-hoc test in B, C, 
I; t test in E. Scale bars: 50 μm in D, H; 10 μm in F. 
See also Figure S2. 
 
Figure 3. Ferroptosis and Lipid Peroxidation Are Key Limiting Factors During Neuronal 
Reprogramming.  
(A, B, D) Histograms showing the percentage of survival and iNs (A, B) or Lipid ROS+ cells (D, N=3, 
for RFP, Bcl-2, A(70)-Bcl-2, Toc; N=4 for EE-Bcl-2 and Ascl1; cells=80-500 each condition) in 
astroglial cultures treated as indicated on the X-axis. Treatment with ZVAD (20μg/µl), Necrostatin (10 
µM) or Liproxstatin-1 (200 nM) was performed at 1DPT (N=4, A,B; cells=1500-2000). 
 (C, E) Confocal micrographs of Lip-Ox (Life Technologies, green reporter) staining (C, treatment with 
cumene hydroperoxide 100 M; positive control for Lip-Ox, or Toc 10 M; negative control for Lip-
Ox, at 1DPT) or C11-Bodipy (E) in astrocytes transfected as indicated at 3.5 DPT. Arrows indicate 
transfected cells (red) with increased levels of Lip-Ox (green); arrowheads transfected cells without 
green signal.   
Error bars indicate ±SD. *p˂0.05, **p˂0.01, ***p˂0.001; ANOVA with Tukey’s post-hoc test in B, D; 
ANOVA with Dunnett’s post-hoc test in A. Scale bars 40 μm.  
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See also Figure S3. 
 
Figure 4. Increased Reprogramming Mediated by a Reduction of Lipid Peroxidation Levels is 
Reproduced by Treatment with Forskolin. 
 (A, B) Histograms show iNs (β-III-tubulin+; green in micrographs in C) and survival rate at 5 DPT 
from astroglial cells transfected and treated as detailed in Figure 3 (N=3; cells=1500-2000). 
(D, E) Micrographs (D) and histogram (E, N=3; cells=110-200) of survival rate/neuronal conversion of 
astroglia transfected with Ascl1/RFP (red cells) and cultured 5 days in absence/presence of 10 µM Fk. 
Neuronal conversion was monitored by β-III-tubulin (green). 
 (F, H) Micrographs showing examples of the C11-Bodipy reporter (F) or CellROX reporter (green in 
H) in astrocyte cultures transfected and treated as indicated at 3.5 DPT.  Arrows depict transfected cells 
(red) with increased levels of ROS (green); empty arrows depict untransfected cells; arrowheads show 
transfected cells with low ROS signal.  
 (G) Quantification of cells depicted in F. The result with Toc treatment has been included to compare 
with the effect of Fk (N=3 for Toc; N=4 in Ascl1 and Ascl1+Fk; cells=80-250). 
(I) Immunoblots showing that 24 h-treatment with Fk reduces the levels of oxidized Prx2 (dimer, upper 
band) in both astroglial cultures (upper panel) and MEFs (lower panel) infected with Ascl1/RFP-
encoding vectors. 
Error bars indicate ±SD. *p˂0.05, **p˂0.01, ***p˂0.001; ANOVA with Dunnett’s post-hoc test in A, 
B, E; ANOVA with Tukey’s post-hoc test in G. Scale bars 40 μm in C and D; 20 μm in F and 80 μm in 
H.  
See also Figure S4 and Movie S3. 
 
 
Figure 5. Transcriptome and Functional Analysis of Genes Activated by Fk and Bcl-2.  
(A) Schematic drawing of the experimental protocol. 
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(B) Heatmaps of linear fold changes with the top 60 up-regulated genes (left) or transcriptional 
regulators (right) in microarrays of Ascl1+Fk vs Ascl1 only transduced MEFs; p<0.01, fold-
change≥1.5.  
(C) Histogram showing qRT-PCR for genes predicted to be regulated by the microarray analysis (ratio 
paired t test, p˂0.01; FC ≥1.5). Genes with lower significance were also validated (p<0.07; shown in 
red).  
(D) Bars represent fold change of luciferase levels from a Nrf2-responsive construct co-transfected 
with Ascl1 in astroglial cultures induced by Fk (15, 24 and 48 h) compared to untreated cells.    
(E) qRT-PCR analysis of mRNA levels from 4 representative targets induced by Fk in MEFs and 
astrocytes. 
(F) Western Blot depicting levels of Vdr protein after 24 h treatment with Fk in astroglia cultures 
infected with RFP- or Ascl1/RFP-encoding retroviral vectors.  
(G) Percentage of astrocytes positive for the lipid reporter based on linoleic acid (Life Technologies) 
among the Ascl1- or Ascl1+Vdr-transfected population at 3.5 DPT. N=3 
(H,I) Histograms and corresponding micrographs (J,K) depicting the neuronal conversion efficiency of 
astroglial cultures transfected with constructs indicated on X axis at 5 DPT (N=3; cells=80-250).  
*p˂0.05, **p˂0.01, ***p˂0.001, ****p<0.0001; ratio paired t test in (C); two-way ANOVA with 
Sidak’s post-hoc test in D; t test in (G); ANOVA with Tukey’s post-hoc test in G, H; ANOVA with 
Dunnett’s comparison test in I. Scale bars: 40 μm. 
See also Figure S5 and Tables S1/S2/S3/S4. 
 
Figure 6. Conversion of Reactive Glia Into Neurons Is Improved by Bcl-2, Calcitriol and -
Tocotrienol In Vivo. 
(A) Scheme of the protocol used for stab-wound injury and subsequent infection with retroviral vectors 
for Neurog2-IRES-RFP and Bcl-2-IRES-GFP, the respective treatments and analysis time points. 
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(B) High-power micrograph of cells infected by Neurog2-IRES-RFP alone or with Bcl-2-IRES-GFP 
stained for NeuN at 10 days post infection (DPI), with orthogonal projections of the confocal stack. 
The RFP+ cell maintains an astroglial morphology and is NeuN-immunonegative (arrows, left panels), 
whereas the co-infected cell displays a distinct neuronal-like morphology and NeuN signal (right 
panels). 
(C-E) Confocal micrographs of the injection site at 10 DPI upon the treatments indicated (C, none; D, 
Calcitriol; E, αT3) stained for NeuN. Co-infected cells immunopositive for NeuN (arrowheads) are 
shown at higher magnification in single optical sections (*,**,***; right panels).  
(F) Histogram with the proportion of induced, NeuN+ neurons amongst RFP+ and RFP+/GFP+ cells at 
10 DPI, without (N=3) or with treatments (calcitriol, N=3; αT3, N=4). 
(G, H) Micrographs of maximum intensity projections of neuronal examples as indicated. Inserts show 
single optical section of the NeuN+ nucleus (*; white arrow). The blue and red boxes in H (**,***) 
display higher magnifications of a process with spine-like structures.  
Error bars indicate ±SD. *p˂0.05, **p˂0.01, ****p˂0.0001; two-way ANOVA with Tukey's post-hoc 
test in F. Scale bars: 10 μm, except 20 μm in B. 
See also Figure S6. 
 
Figure 7. Subtype Identity of Induced Neurons After Stab-wound Injury. 
(A, B) Confocal micrographs (maximum intensity projection, A) and histogram of soma size (B) of cells 
at 10 days post infection by Neurog2/RFP and Bcl-2/GFP retroviral vectors after stab-wound injury and 
T3 treatment (see Figure 6A) with thick processes and spine-like structures (box X, left panel). The 
soma size of these cells (NeuN staining, magnified in boxes *,**,***; arrowheads) is similar to the size 
of nearby endogenous neurons (arrows), unlike for mice that did not receive T3 (right panel, magnified 
in ****). 
(C-F) Confocal micrographs showing neuronal subtype markers FoxP2 (C), Ctip2 (D), GABA (E), 
Satb2 and Cux1 (F) at 10 DPI. Filled arrowheads indicate immunopositive, empty arrowheads 
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immunonegative cells in the squared box (*,**). Specific examples of cells located in upper or deep 
layers are depicted in F. 
(G) Histogram of double infected cells expressing the indicated markers. 
Horizontal lines in B indicate the mean. N=4 in A and B (αT3); N=3 in B (no treatment and calcitriol), 
C, D and G for Ctip2 and FoxP2; N=2 in E, F and G for Cux1 and Satb2. *p˂0.05; one-way ANOVA 
with Tukey's post-hoc test in B. Scale bars: 10 μm. 
See also Figure S7. 
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Emb 17290083 7.0E-07 10.21
Vdr 17321078 0.00003 9.49
Tmem100 17255058 1.5E-07 8.63
Nppc 17225191 0.00021 8.13
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Shisa6 17264282 0.00089 4.84
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Pi16 17335506 0.00030 3.04
Kcne4 17214711 0.00121 3.01
Nnat 17393764 0.00190 2.98
Pde10a 17333133 0.00014 2.92
Il1r1 17212185 0.00034 2.92
Chst11 17235941 0.00054 2.88
Tgfbr3 17450618 0.00046 2.88
Hdac4 17225531 0.00046 2.87
Spry3 17546246 0.00039 2.76
Emilin2 17346975 0.00003 2.75
Sod3 17437385 0.00230 2.75
Arrdc3 17288876 0.00007 2.71
Sorcs2 17447404 0.00623 2.71
Mcpt8 17306968 0.00729 2.64
Table S1
Nrcam 17275255 0.00001 2.63
Cd55 17226622 0.00029 2.58
Has2 17317167 0.00053 2.56
Gm15675 17226618 0.00004 2.54
Tgfbi 17287827 0.00003 2.51
Gem 17411840 0.00137 2.50
Pde8a 17479668 0.00003 2.48
Hdac4 17225535 0.00004 2.43
Ucma 17366525 0.00714 2.41
Prox1 17230960 0.00057 2.41
Igfbp4 17256264 0.00003 2.40
Xdh 17347163 0.00280 2.39
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Mt2 17503937 0.00107 2.36
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Bcl3 17487457 0.00400 2.33
Ppap2b 17416234 0.00046 2.30
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Rspo1 17418403 0.00202 2.23
Gm16277 17360728 0.00857 2.23
Ppp1r3c 17364208 0.00102 2.21
Adam12 17497246 0.00006 2.20
Timp1 17533713 0.00025 2.19
Slc1a3 17315860 0.00036 2.19
Tnfaip6 17370735 0.00220 2.18
Bace2 17327544 0.00146 2.16
17291193 17291193 0.00374 2.16
Myo7a 17493467 0.00029 2.15
Angptl4 17343628 0.00704 2.15
Ndnf 17459207 0.00033 2.14
Crabp2 17398895 0.00015 2.11
ENSMUST00000107353239 0.00612 2.11
Tubb3 17506631 0.00522 2.10
Cd24a 17240606 0.00076 2.10
Tes 17548534 0.00001 2.09
Gdf10 17298731 0.00298 2.09
Srgap1 17245539 0.00116 2.08
Errfi1 17421972 0.00004 2.07
Slco2a1 17520905 0.00139 2.06
Slc16a2 17543817 0.00039 2.06
Dusp10 17220475 0.00030 2.04
Fbln1 17313811 0.00079 2.04
Pde3a 17464040 0.00256 2.02
Slc16a1 17401335 0.00057 2.01
Csrp2 17237208 0.00126 2.01
LOC100038987 17366314 0.00994 2.00
Tspan11 17463387 0.00203 1.99
Dpt 17218927 0.00253 1.98
Sfrp1 17500068 0.00141 1.97
Gm23320 17535987 0.00454 1.97
Cdh6 17316120 0.00008 1.96
Cables1 17348435 0.00076 1.96
Tnfsf11 17308817 0.00072 1.95
Ank3 17234066 0.00198 1.95
Aff2 17535245 0.00089 1.94
Ralgds 17368685 0.00169 1.94
Tnfrsf23 17498323 0.00098 1.93
Sned1 17215932 0.00127 1.93
Sox11 17280350 0.00020 1.92
Mgst1 17463909 0.00035 1.90
Plekhg1 17231366 0.00152 1.90
Gm20186 17456281 0.00017 1.90
Tes 17456131 0.00081 1.90
Tbx18 17529481 0.00139 1.90
Nap1l5 17467205 0.00598 1.90
S1pr3 17287325 0.00098 1.89
Ets2 17327465 0.00122 1.89
Slit3 17248426 0.00439 1.89
Maf 17513289 0.00361 1.88
Lrig1 17469217 0.00109 1.88
Pde4b 17416023 0.00044 1.87
Kif26b 17219997 0.00096 1.87
Hsph1 17455507 0.00305 1.86
BC028471 17444970 0.00189 1.86
Pde8b 17295059 0.00377 1.85
Socs3 17547600 0.00676 1.85
Pdgfra 17438246 0.00421 1.84
Phf17 17397344 0.00551 1.84
Gm10007 17360731 0.00267 1.84
Agtr1a 17286271 0.00601 1.84
Tiparp 17548270 0.00424 1.83
Hand2 17501272 0.00161 1.83
Mmp12 17514495 0.00590 1.83
A130040M12Rik17267418 0.00522 1.83
ENSMUST00000157448166 0.00187 1.82
Slc10a6 17450319 0.00276 1.81
Rassf2 17391920 0.00495 1.81
Mt1 17503942 0.00168 1.81
Galnt2 17506732 0.00487 1.81
Cdkn1c 17498245 0.00031 1.81
Enpep 17410251 0.00320 1.81
Kcnd2 17456308 0.00177 1.80
Hgf 17434933 0.00039 1.80
Sox9 17257946 0.00813 1.80
Plxna2 17220974 0.00153 1.78
Cpa4 17456886 0.00213 1.78
Scgb1c1 17484610 0.00030 1.77
Nr2f1 17294547 0.00743 1.77
Ptchd1 17545618 0.00008 1.77
Pde1c 17467072 0.00211 1.76
Tmem178b 17457550 0.00181 1.76
Plat 17499962 0.00276 1.76
Ier5l 17383663 0.00484 1.76
Gclm 17402283 0.00409 1.76
Edil3 17288992 0.00039 1.76
Gdf6 17411727 0.00129 1.76
Wnt4 17420154 0.00348 1.75
9330133O14Rik 17506398 0.00053 1.74
Cdh4 17380659 0.00119 1.73
Kitl 17236900 0.00197 1.73
Acsl4 17545051 0.00064 1.73
Adcy2 17294086 0.00009 1.72
Mef2d 17398970 0.00364 1.72
ENSMUST0000017232438 0.00769 1.71
Agtr2 17533746 0.00271 1.70
Pappa 17414802 0.00147 1.70
Zfp930 17501672 0.00918 1.69
Htr3a 17526717 0.00025 1.69
Lpar1 17425686 0.00038 1.68
Gchfr 17374738 0.00178 1.68
Gpr137b 17290695 0.00843 1.68
B3galt1 17371310 0.00161 1.68
Ier3 17337228 0.00882 1.68
Abca1 17425301 0.00588 1.68
Gprc5b 17495610 0.00017 1.68
Plagl1 17231694 0.00033 1.68
Atp1b1 17229178 0.00077 1.67
Acvr1b 17315152 0.00705 1.67
Ptk7 17345475 0.00363 1.67
Pkdcc 17339973 0.00334 1.66
Calca 17495328 0.00008 1.66
Angpt1 17316780 0.00275 1.65
Steap1 17445440 0.00043 1.65
Gdf5 17393390 0.00054 1.65
Slc16a3 17259534 0.00965 1.64
Clstn2 17529930 0.00132 1.64
Rybp 17469463 0.00665 1.63
Il1rl2 17212199 0.00579 1.63
Fzd1 17445325 0.00261 1.63
Car13 17396143 0.00015 1.63
1810022K09Rik 17404174 0.00717 1.63
LOC101056010 17227379 0.00939 1.62
2300009N04Rik 17330625 0.00811 1.62
Nr4a3 17413945 0.00537 1.62
Tmem189 17394727 0.00961 1.61
Nfatc4 17300672 0.00081 1.61
Gdpd1 17267430 0.00071 1.61
Vipr2 17279562 0.00473 1.61
Tm7sf2 17361921 0.00734 1.60
Lypd1 17226435 0.00636 1.60
Ecm1 17407850 0.00392 1.60
Olfr311 17250115 0.00251 1.60
Apbb1ip 17367536 0.00234 1.60
Kremen1 17260137 0.00371 1.60
Gdf11 17246352 0.00952 1.60
Syt13 17373530 0.00738 1.60
Thpo 17329195 0.00629 1.60
Epb4.1l3 17339313 0.00046 1.59
Enpp1 17239787 0.00084 1.59
Has1 17341269 0.00384 1.59
Tiparp 17398082 0.00298 1.58
Cntfr 17424279 0.00939 1.58
AI593442 17527027 0.00355 1.58
Sdk2 17271632 0.00279 1.58
Il4ra 17482943 0.00446 1.58
Add3 17360312 0.00200 1.57
Clmp 17516352 0.00048 1.57
Slc6a17 17409005 0.00168 1.56
Sbsn 17476528 0.00042 1.56
Irak3 17245399 0.00240 1.56
Kif21a 17320614 0.00077 1.56
Nod1 17467015 0.00708 1.55
Nfe2l2 17386700 0.00364 1.55
ENSMUST00000157221434 0.00927 1.54
Gm5595 17490078 0.00153 1.54
Hs3st1 17447726 0.00334 1.54
Atp8b1 17355026 0.00620 1.54
Lrrc32 17480485 0.00636 1.53
Arl4c 17225360 0.00060 1.53
Rhou 17506697 0.00060 1.53
S100a14 17399776 0.00639 1.53
Cntn1 17314387 0.00506 1.53
Osmr 17315743 0.00572 1.53
Mpi 17527532 0.00726 1.53
LOC100862618 17258023 0.00144 1.53
Steap2 17445426 0.00221 1.52
Zfp503 17303989 0.00175 1.52
Ypel4 17372592 0.00051 1.52
Cirbp 17235227 0.00882 1.52
Lmo1 17494842 0.00172 1.52
Gna14 17357971 0.00421 1.51
Dclk1 17397708 0.00439 1.51
Flywch2 17341619 0.00372 1.51
Gm16564 17230301 0.00055 1.51
Cpt1a 17355915 0.00760 1.51
Mthfd2l 17439003 0.00432 1.50
U90926 17449649 0.00881 1.50
Slc4a7 17297227 0.00137 1.50
Stat3 17269717 0.00458 1.50
4931406H21Rik 17297748 0.00508 1.50
Tsnax 17506854 0.00676 1.50
Krt5 17321966 0.00042 1.50
Usp2 17516469 0.00457 1.50
Gm3696 17303088 0.00667 -1.50
Ablim1 17365911 0.00307 -1.50
Myo1c 17253055 0.00320 -1.50
Pdlim2 17308242 0.00181 -1.50
Ptp4a3 17312127 0.00411 -1.51
Dmd 17536078 0.00434 -1.51
LOC381967 17493653 0.00484 -1.51
Ano3 17389161 0.00842 -1.51
Slc7a3 17543529 0.00930 -1.52
Shmt1 17263673 0.00241 -1.52
Pycard 17496839 0.00767 -1.53
Ptplad2 17427051 0.00750 -1.53
Tmpo 17244191 0.00334 -1.53
Slc35f1 17233306 0.00901 -1.53
Alcam 17330918 0.00058 -1.53
Wbscr17 17453222 0.00403 -1.54
Tead4 17471278 0.00184 -1.54
Cyb5r2 17494739 0.00653 -1.54
Plxdc2 17367216 0.00338 -1.54
Inpp1 17222940 0.00051 -1.54
Abhd17c 17492978 0.00040 -1.54
Cdh2 17549842 0.00130 -1.54
Lrrtm1 17459735 0.00830 -1.54
Palm2 17414351 0.00139 -1.54
Samd5 17239142 0.00099 -1.55
Rprm 17385365 0.00704 -1.55
Ppnr 17360532 0.00521 -1.55
Dock11 17533994 0.00119 -1.55
Prss23 17493212 0.00510 -1.55
4632434I11Rik 17493358 0.00256 -1.55
C3ar1 17470616 0.00422 -1.55
Dgkh 17308842 0.00392 -1.55
Dner 17224977 0.00677 -1.55
Mylk 17325159 0.00121 -1.55
Gm13889 17388548 0.00668 -1.56
Limch1 17437887 0.00043 -1.56
Ifih1 17385797 0.00202 -1.56
Trav9d-3 17300054 0.00146 -1.56
Gpsm2 17409386 0.00621 -1.56
Tnr 17218568 0.00199 -1.57
Gm10561 17212900 0.00320 -1.57
ENSMUST00000157451884 0.00520 -1.57
Acy1 17530669 0.00146 -1.58
Dennd4a 17518378 0.00044 -1.58
Smarca1 17541343 0.00552 -1.58
Adra1d 17391899 0.00341 -1.58
Arhgap21 17382104 0.00049 -1.58
Eml1 17278561 0.00203 -1.59
Mlkl 17513076 0.00686 -1.59
Rps12 17239755 0.00290 -1.59
17216751 17216751 0.00764 -1.59
Notch3 17343299 0.00511 -1.59
Gm4070 17494643 0.00480 -1.59
Adam23 17213608 0.00042 -1.59
Bche 17405908 0.00339 -1.59
Zfp953 17293945 0.00282 -1.60
Gm18853 17494662 0.00937 -1.60
Bbs12 17397120 0.00183 -1.60
Pcp4 17327539 0.00545 -1.60
ENSMUST000000817513854 0.00471 -1.60
Tnfrsf26 17498301 0.00399 -1.60
Fras1 17439388 0.00367 -1.61
Myh10 17251370 0.00430 -1.61
Grip1 17237608 0.00031 -1.61
Mid2 17538171 0.00959 -1.61
Slc27a6 17350856 0.00419 -1.61
Morc4 17544878 0.00299 -1.61
Ptprb 17237451 0.00511 -1.62
ENSMUST00000107237033 0.00354 -1.62
Cdh2 17352884 0.00289 -1.62
Cnksr3 17239023 0.00195 -1.62
Vps13a 17363239 0.00104 -1.62
17415231 17415231 0.00376 -1.63
Gm20276 17547535 0.00701 -1.63
Spp1 17439830 0.00969 -1.64
Trp53cor1 17342996 0.00511 -1.64
LOC101055758 17225080 0.00051 -1.65
1190005I06Rik 17513534 0.00134 -1.65
Tceal5 17544725 0.00117 -1.65
Cspg4 17517592 0.00765 -1.66
Rspo2 17316793 0.00315 -1.66
Nkain4 17395707 0.00852 -1.66
Swap70 17481755 0.00023 -1.66
Mir1198 17533002 0.00461 -1.66
Col4a5 17538222 0.00226 -1.67
Cd109 17519738 0.00026 -1.69
Gm10855 17381511 0.00125 -1.69
Frmd3 17414913 0.00318 -1.69
Wisp1 17312022 0.00154 -1.69
Mef2c 17294682 0.00685 -1.69
Nedd9 17292071 0.00014 -1.71
Gabrb1 17438022 0.00040 -1.71
Ntn4 17236604 0.00019 -1.72
Erp27 17472199 0.00570 -1.72
Sync 17418976 0.00536 -1.72
2610016A17Rik 17363670 0.00133 -1.72
Itga11 17518191 0.00262 -1.73
Gm20038 17548135 0.00759 -1.73
Adh7 17403058 0.00337 -1.73
Arid5b 17241660 0.00202 -1.73
1700086L19Rik 17276375 0.00993 -1.74
Cyth3 17444372 0.00142 -1.74
Med13 17254629 0.00830 -1.74
Slc7a11 17405082 0.00071 -1.74
Isoc1 17350869 0.00042 -1.74
Myoc 17218752 0.00064 -1.74
Jph2 17394015 0.00797 -1.74
Maml2 17514678 0.00142 -1.74
Arhgef10 17499447 0.00050 -1.75
Itga8 17381717 0.00034 -1.75
Arhgap20 17517222 0.00656 -1.76
Robo2 17331481 0.00007 -1.76
Dock10 17224813 0.00501 -1.76
Ecscr 17353650 0.00301 -1.76
1700007K13Rik 17383373 0.00467 -1.77
Slc35f1 17240817 0.00047 -1.77
Gm9581 17331306 0.00073 -1.77
Aff3 17222465 0.00035 -1.78
Hspb1 17443342 0.00225 -1.78
8430431K14Rik 17363925 0.00637 -1.79
Slc7a11 17397421 0.00184 -1.80
Jag1 17392151 0.00094 -1.80
Myh1 17251046 0.00176 -1.80
Gm19705 17217825 0.00407 -1.81
Gpc4 17541668 0.00083 -1.82
Nexn 17411201 0.00012 -1.82
Ptk2b 17307860 0.00043 -1.83
Fmod 17217373 0.00175 -1.83
Gucy1b3 17406205 0.00155 -1.83
Ptprq 17244737 0.00020 -1.84
Pdlim1 17364474 0.00112 -1.84
Gca 17371201 0.00120 -1.84
Mtap7d3 17541856 0.00191 -1.84
Enpp5 17337844 0.00043 -1.85
Cilp 17518512 0.00457 -1.85
Fam198b 17398406 0.00012 -1.85
Prrg4 17388999 0.00005 -1.86
ENSMUST000000817525892 0.00379 -1.87
Gm9817 17286958 0.00015 -1.87
Arxes2 17537861 0.00299 -1.87
LOC101055663 17366278 0.00111 -1.87
Vcl 17297551 0.00164 -1.87
Gpr176 17389709 0.00012 -1.87
Spta1 17219698 0.00132 -1.88
Adamts12 17310368 0.00007 -1.88
4933400A11Rik 17546205 0.00814 -1.88
Pgm5 17363626 0.00030 -1.89
Defa-rs1 17507910 0.00638 -1.89
Slc1a6 17234833 0.00028 -1.90
Tns3 17260487 0.00035 -1.90
Mustn1 17298262 0.00332 -1.91
Col12a1 17529099 0.00036 -1.91
Olfr1318 17374214 0.00221 -1.92
Gpr64 17539271 0.00149 -1.93
Enpp4 17345124 0.00120 -1.93
Ccdc141 17387131 0.00183 -1.93
Ifit2 17358815 0.00004 -1.94
GENSCAN000000317548979 0.00031 -1.94
Ak5 17411235 0.00018 -1.95
Pltp 17394297 0.00046 -1.95
Gm4951 17350916 0.00559 -1.95
Tnc 17426365 0.00911 -1.96
Fmod 17227083 0.00055 -1.96
Nes 17398903 0.00029 -1.97
Gnai1 17445735 0.00171 -1.97
Myh2 17251001 0.00136 -1.97
Gas2 17478476 0.00181 -1.97
Slfn2 17254166 0.00368 -1.97
Lmo7 17302429 0.00013 -1.99
Galnt18 17495172 0.00145 -1.99
Calml4 17518238 0.00137 -1.99
Itga4 17372307 0.00562 -2.01
Gm19274 17548671 0.00168 -2.02
Cryab 17548750 0.00013 -2.03
Cd80 17325608 0.00010 -2.03
Foxs1 17393004 0.00151 -2.04
Lmcd1 17461477 0.00014 -2.04
Upk1b 17330427 0.00520 -2.05
Edn1 17286830 0.00003 -2.06
Col8a1 17331162 0.00148 -2.07
Gm13362 17382101 0.00019 -2.07
Lims2 17349209 0.00114 -2.10
Susd2 17241849 0.00039 -2.10
Pld5 17230176 0.00210 -2.11
Mtss1 17317327 0.00012 -2.11
Adamts1 17331705 0.00023 -2.12
Etl4 17367390 0.00026 -2.14
Bmp3 17439535 0.00007 -2.14
Meox2 17275062 0.00026 -2.14
Pi15 17211305 0.00021 -2.15
Fhl2 17222642 0.00022 -2.15
Fam101b 17266038 0.00068 -2.15
Serpine1 17453819 0.00144 -2.18
Ccdc80 17325904 0.00059 -2.19
Tslp 17349304 0.00031 -2.19
2310022B05Rik 17514087 0.00005 -2.20
Cntnap3 17293721 0.00425 -2.20
Adamts14 17547499 0.00575 -2.21
Fat3 17524233 0.00020 -2.21
ENSMUST00000157297591 0.00003 -2.22
GM8989 17494664 0.00362 -2.24
Pdlim3 17500922 0.00215 -2.25
Sdpr 17212719 0.00177 -2.25
Cryab 17517132 0.00019 -2.29
4833412C05Rik 17492031 0.00161 -2.30
Adh1 17403070 0.00252 -2.30
Cdc42ep3 17347435 0.00021 -2.30
Abi3bp 17326318 0.00235 -2.33
Ppp1r14a 17476119 0.00109 -2.38
Figf 17539536 0.00809 -2.38
Tnfsf18 17218707 0.00245 -2.38
Rcan2 17337834 0.00026 -2.39
Sorbs2 17500876 2.9E-06 -2.40
Gpr126 17239435 0.00033 -2.42
Eln 17453454 0.00062 -2.42
F11r 17219362 0.00165 -2.44
Ccdc80 17330612 0.00265 -2.50
Insc 17482047 0.00007 -2.51
Mir3093 17399008 0.00069 -2.54
Arhgef6 17541875 0.00009 -2.55
Col14a1 17311551 0.00003 -2.56
ENSMUST0000017550036 0.00420 -2.58
Pawr 17237170 0.00102 -2.60
Lbh 17339554 0.00240 -2.65
Phxr4 17514687 0.00040 -2.66
Klf5 17302397 0.00001 -2.68
Flt1 17455346 0.00022 -2.69
Ptprz1 17456381 0.00021 -2.69
Cpa6 17221269 0.00018 -2.71
Adrb2 17354857 0.00002 -2.74
n412642 17381351 0.00172 -2.78
Gm4070 17494651 0.00122 -2.91
Adm 17481770 0.00006 -2.91
Itgbl1 17302936 0.00002 -2.98
Sprr3 17407407 0.00040 -3.05
Ctgf 17232235 0.00451 -3.15
Gm10808 17547949 0.00312 -3.30
Bex1 17544734 0.00505 -3.55
9930013L23Rik 17492947 0.00826 -3.66
Trav9d-3 17300247 0.00033 -3.68
Map3k7cl 17326887 0.00017 -4.02
Gucy1a3 17406221 0.00008 -4.62
Ccl20 17214857 0.00012 -4.63
Meox1 17269974 4.8E-06 -5.23
Prl3a1 17286158 1.1E-06 -9.05
Supplemental Figures and Legends 
 
Figure S1. Related to Figure 1 
Validation of the Morphological Criteria. 
(A) Description of the morphological criteria used to classify cells as “non-neuronal/astroglial” or “neuronal” in the 
time-lapse movies. Cells with at least one thin process (ф˂3 µm) 3x longer than the soma were classified as “neuronal”. 
The cell soma was designated as an ellipsoid located at the most prominent swelling part of the cell, at the level where 
the nucleus is located (visible by accumulation of RFP fluorescence). The largest diameter of the ellipsoid was 
measured and compared to the length of the longest thin process (see examples).  For the morphometric analysis and the 
video tracking of single cells we used the software ImageJ (FIJI version). 
(B) Examples of astrocytes transfected with Ascl1 and RFP-encoding plasmid at 5 DPT classified according to 
morphological criteria. Cells classified as neurons (lower panels) are immune-reactive for the neuronal markers β-III-
tubulin, MAP2 and NeuN, contrary to cells with an astrocyte morphology (upper panels). 
(C, D) Histograms show quantifications of the analysis from B in cultures transfected with Ascl1/RFP alone (C) or in 
combination with Bcl-2 (D).  
(E) Immunocytochemistry showing that some “non-neuronal/astroglial” cells (upper panels) transduced with Ascl1 co-
express both neuronal (β-III-tubulin, white) and astroglial (GFAP, green) markers at 5 DPT. Contrarily, cells with 
neuronal morphology (lower panels) only express neuronal markers (β-III-tubulin). 
Error bars indicate ±SD. Scale bars: 20 μm in (B, E) and 40 μm in (A). 
 
Supplemental Figures & Text
  
Figure S2. Related to Figure 2 
Analysis of Neuronal Conversion by DCX-GFP, Expression of Neuronal Markers and Electrophysiology. 
(A) Still images from time-lapse movies (Figure 1A and Movie S2) show astroglial cells (blue arrows), DCX-GFP+ 
neurons (purple arrows, GFP reporter column) and dying cells (red arrows) at different time points in cultures co-
transfected with only DCX-GFP and Ascl1 (left panels) or in combination with Bcl-2 (right panels). 
(B) Progeny-trees of single cells tracked from the examples in A showing that cells rarely proliferate during 
reprogramming. Most astroglial cells (blue lines) do not turn directly into DCX-GFP neurons (purple lines) and die 
(depicted with “x”) before converting.  
(C) Percent of transfected cells that newly acquire DCX-GFP signal at different time-points in the movies from A. 1095 
and 220 cells were counted in Ascl1 and Ascl1+Bcl-2, respectively. 
(D, E) Histograms showing the percent of cells immune-reactive for neuronal markers or having a neuronal shape, as 
indicated, among the transfected (RFP+) cells at 5 DPT (N=3). 
(F) Patch-clamp recordings from the cells transfected with only Ascl1/RFP (1-2) or in combination with Bcl-2 (3, 4) at 
5 DPT. The left panels show brightfield with a patch electrode attached (up) and red-fluorescence (down). On the right, 
the resting membrane potential and voltage-clamp is shown for all the examples. In the example 3, a current-clamp 
displays very immature action potential-like features elicited by co-transfection with Ascl1/RFP and Bcl-2. 
(G) Histogram shows quantification of resting membrane potential (RMP) in short/long cells transfected with only 
Ascl1 or in combination with Bcl-2. N=6 cells in Ascl1/long-short cells; N=10 cells in Ascl1+Bcl-2/long cells; N=8 
cells in Ascl1+Bcl-2/short cells. Note that a higher number of cells has a neuronal morphology upon Bcl-2 co-
transduction (E) and hence a higher number of cells has a more positive RMP. 
(H) Recordings from a cell transfected with Ascl1 and Bcl-2 at 15 DPT show a current-clamp trace elicited by 50 pA 
current injection with notable mature action potentials. 
Error bars indicate ±SD. *p 0.05, **p˂0.01, ***p˂0.001, ****p˂0.0001; unpaired t test in D, E, G. Scale bars 50 μm in 
A, 40 μm in F, H. 
See also Movie S2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure S3. Related to Figure 3 
Bcl-2 and A(70)-Bcl-2 Enhance Neuronal Conversion of MEFs. 
(A, B) Epifluorescence images of MEF cultures co-infected with Ascl1/RFP- (A) or Neurog2/RFP- (B) encoding viral 
vectors in combination with the GFP control or Bcl-2/GFP-encoding viral vectors. Note that Bcl-2 increases the number 
of neurons immunoreactive for β-III-tubulin obtained at 14 DPI (lower panels; white cells). 
(C) Histogram showing the quantifications of experiments from A and B (N=4). 
(D) Electrophysiological recordings from the cell infected with Ascl1 and Bcl-2 and shown in brightfield in the lowest 
panel with a patch electrode attached. On the top panel, a current-clamp trace elicited by 50 pA current injection is 
shown revealing a train of action potentials, while the middle panel shows voltage-clamp traces with notable fast-
inactivating inward currents. 
(E) Epifluorescence images of MEF cultures transduced with the retroviral vector Neurog2-IRES-A(70)-Bcl-2. Note the 
high proportion of neurons immunoreactive for β-III-tubulin (green) among the transduced population (flag+; red). 
(F) Histogram showing the high increase in the conversion efficiency mediated by Neurog2- and A(70)-Bcl-2-co-
expression compared to the Neurog2-only transduced controls (N=3). 
Error bars indicate ±SD. **p˂0.01; unpaired t test in C, F. Scale bars: 40 μm. 
 Figure S4. Related to Figure 4 
Analysis of Astrocyte-to-Neuron Conversion upon Forskolin Treatment by Live Imaging. 
(A) Examples of still images from time-lapse movies (see Movie S3) show astroglial cells (green arrows), neurons 
(yellow arrows) and dying cells (red arrows) at different time points, in the presence or absence of Fk. Last image shows 
immunostaining of fixed cells confirming that all RFP+ cells are neurons (yellow arrows) expressing β-III-tubulin 
(green). Note that at the end of the movie, the number of neurons increased in Fk treated cultures (20 μM). 
(B) Progeny-trees of single cells tracked from example in A showing that cells rarely proliferate during reprogramming 
and most astroglial cells (green lines) die (dead cells depicted with “x”) before they could become neurons (yellow 
lines). Fk treatment (right diagram) resulted in faster acquisition of neuronal morphology, reduced cell death and 
increased reprogramming efficiency.  
(C) Analysis of neuronal conversion and cell survival during the observation period, in Fk treated and untreated cultures. 
The total number of astrocytes/neurons (white and black bars, respectively) is normalized to the initial number of 
transfected cells analysed at 1 DPT.  
(D) Histogram showing that neurons appear mostly in the first half of imaging time upon Fk treatment. 
(E) Histogram of the proportion of Ascl1-transfected cells proliferating during 150 h of observation with or without Fk 
treatment. Note that this value is low and not significantly increased upon Fk treatment.  
(F) Micrograph showing that Fk does not induce neuronal conversion of astrocytes (β-III-tubulin, Red) without the 
expression of neuronal fate determinants.  
N=5 in the control condition (339 initial tracked cells); N=4 in Fk treated condition (195 cells). 
Error bars indicate ±SD. *p˂0.05, **p˂0.01, ***p˂0.001, p≥0.05 no statistically significant difference (n.s.); ANOVA 
with Tukey’s post-hoc test in C; unpaired t test in D, E. Scale bars: 40 μm. 
See also Movie S3. 
 
 
 
 
 
 
 
 
 
 Figure S5. Related to Figure 5 
Widespread Effect of Forskolin in Enhancing Neuronal Reprogramming  
(A, B) Micrographs showing Ascl1- or Neurog2-transduced MEFs analysed for β-III-tubulin immunoreactivity (green) 
14 days after retroviral infection. MEF-derived neurons exhibit longer and more complex processes upon Fk treatment 
(boxed areas 1 and 2 magnified in the lower panels).  
(C) Histogram showing the proportion of β-III-tubulin+ neurons amongst control (white bars), Ascl1 (grey bars) or 
Neurog2 (black bars) transduced (RFP+) MEFs upon Fk treatment (N=3). 
(D) Micrograph showing highly complex β-III-tubulin+ processes (upper right panel) of Ascl1-infected MEFs (upper left 
panel, green cells) upon Fk addition at 25 DPI. Lower panel shows high magnification view of β-III-tubulin+ (red) 
neurites with high density of synaptobrevin (SV) puncta (green) indicating synaptic contacts. 
(E) Epifluorescence images of human pericyte-derived neurons showing β-III-tubulin-immunoreactivity (red) 4 weeks 
after infection with a viral vector co-expressing Ascl1, Sox2 and GFP (green) in cultures with (right panels) or without 
Fk addition. After Fk treatment neurons show more mature morphology, with more complex and extended neurites. 
(F) Histogram depicting the proportion of β-III-tubulin-immunoreactive cells from (E) amongst all GFP+ transduced 
cells (N=3). 
Error bars indicate ±SD. Statistical tests performed on treated and untreated cells transduced with the same transcription 
factor (Control, Ascl1, Neurog2, Dlx2). *p˂0.05, **p˂0.01, ***p˂0.001; unpaired t test. Scale bars: 40 μm. 
 
 
 
 
 
 
Figure S6. Related to Figure 6 
Calcitriol Enhances Neurog2-Mediated Reprogramming of MEFs In Vitro and Glial Cells After stab wound 
Injury In Vivo.  
(A) Epifluorescence micrographs of MEF cultures 10 days after co-transduction with Neurog2/RFP and Bcl-2/GFP in 
the absence (upper row) or presence (lower row) of calcitriol. Higher magnification (right column) of the insets shows 
the beneficial effects of calcitriol. 
(B) Histogram depicting the proportion of β-III-tubulin-immunoreactive cells amongst the MEFs co-infected with 
Neurog2/RFP and Bcl-2/GFP with or without calcitriol, at 10 days after retroviral transduction. 
(C) Confocal micrographs (maximum intensity projection) of cells infected by the retroviral vector encoding for GFP in 
vivo after stab-wound injury and immunostained for NG2, GFAP and Doublecortin (DCX) at 7 days post-injection 
(DPI). GFP+ cells are NG2+ (left panel, arrow) or GFAP+ (right panels, arrowheads). No DCX+ cells were detected 
around the lesion site. 
 (D) Quantifications of NeuN/RFP double-positive cells after stab-wound injury and subsequent injection with 
Neurog2/RFP in vivo. Mice were treated or not with calcitriol and analysed at 10 DPI as depicted in Figure 6A. 
(E) Confocal micrographs of the injection site (10 DPI, maximum intensity projection) and immunohistochemistry for 
DCX. The cells in the insets (*,**) are shown at higher magnification, with white arrowheads indicating the co-
localization of the processes with DCX. 
(F) Cells infected by Neurog2/RFP alone or with Bcl-2/GFP after stab-wound injury in vivo, analyzed at 10 DPI after 
treatment with calcitriol (Figure 6A), with magnified single optical sections (*,**) shown on the right. Some RFP+ cells 
(transduced with Neurog2 only) are NeuN-immunopositive (arrow), whereas GFP+ cells (transduced only with Bcl-2) 
never do (empty arrowheads). Co-infected cells are frequently NeuN+ (filled arrowheads).  
(G) Confocal micrographs (maximum intensity projection) showing neurons co-transduced in vivo (10 DPI) after 
treatment with calcitriol. Purple arrowheads indicate neurites emerging from adjacent neurons and growing towards the 
pial surface (above) and the white matter (below). High magnification panels on the right (*,**) show that both neurons 
have high levels of NeuN (white arrowheads), comparable to those found in native neurons around the same area (white 
arrows).   
(H) Confocal micrographs (maximum intensity projection) of cells co-infected by Neurog2/RFP and Bcl-2/GFP 
(magnified in boxes *, ** and ***; arrowheads) after treatment with calcitriol are immunoreactive for NeuN at 60 DPI. 
Note that their soma size is comparable to the one displayed by surrounding endogenous neurons (arrows). The picture at 
the bottom shows single infected cells (RFP+ or GFP+) still viable after 60 DPI and maintaining their glial nature. 
Error bars indicate ±SD. N=1 in C, E, H; N=3 in A, B, D, F, G **p˂0.01; unpaired t test in B, D. Scale bars: 40 μm in A 
and 10 μm in C, E, F-H. 
 Figure S7. Related to Figure 7 
Maintaining Glycolysis in Astroglial Cells Reduces Oxidative Stress but Blocks Reprogramming Into Neurons. 
(A) Quantification of experiments with examples of cells shown in B depicting the % of neuronal conversion normalized 
to the initial number of transfected cells (1 DPT; grey bars), at the end point (5 DPT; blue bars) and % of surviving cells 
(black bars) grown in anaerobic glycolysis-only, OxPhos-only or control medium. Note that all cells grown in OxPhos 
medium die, while cells grown in anaerobic glycolysis medium survive but fail to convert into neurons. 
(B) Micrographs of astroglial cultures transfected with Ascl1/RFP and maintained in culture for 5 days in normal 
differentiation medium (control medium) or anaerobic glycolysis medium. As previously, neuronal conversion was 
monitored by β-III-tubulin immunoreactivity (green) among the transfected population (RFP+, red). Note that cells in 
glycolysis only medium do not acquire β-III-tubulin. 
(C) Micrographs showing representative examples of Lip-Ox evaluated by C11-Bodipy reaction (green channel), of 
Ascl1/RFP transfected cells (RFP+, red) 24 hours after change with medium capable of inducing selective metabolisms 
(control medium, anaerobic glycolysis-only medium, OxPhos-only medium). Arrows indicate transfected cells (red) with 
increased levels of Lip-Ox (green); arrowheads transfected cells without green signal. Note that anaerobic glycolysis 
medium reduces Lip-Ox in transfected cells, while OxPhos medium potently increases it compared to Control medium. 
(D) Micrographs of astroglial culture at 24h in the anaerobic glycolysis-only medium already shows much reduced ROS 
signal detected by the superoxide indicator dye Dihydroethidium (DHE, 5μM, Life Technologies), which shifts from a 
blue fluorescence in the cytosol to a red fluorescence in the nucleus when oxidized.  
(E) Micrographs of astroglial cultures transduced with Neurog2/RFP and maintained 7 days in normal differentiation 
medium (control Medium, left), anaerobic glycolysis-only medium (middle) or OxPhos-only medium (right). Neuronal 
conversion was monitored by β-III-tubulin immunoreactivity (green) among the transfected cells (RFP+, red). Note that 
also Neurog2-induced reprogramming is impaired in anaerobic glycolysis medium, while cells do not survive in 
OxPhos-only metabolism. 
(F) Quantification of the experiment in E showing that the % of neuronal conversion normalized to the final number of 
transduced cells (β-III-tubulin/RFP at 7 DPI; grey bars) is drastically reduced when cells are grown in anaerobic 
glycolysis medium, while % of surviving cells (RFP/total DAPI at 7 DPI; black bars) is unaffected. 
Error bars indicate ±SD. *p<0.05, **p˂0.01; ****p<0.0001; ANOVA with Tukey’s post-hoc test in A; ANOVA with 
Holm-Sidak’s post-hoc test in F. Scale bars: 40 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental tables 
Table S1 as Excel file. Related to Figure 5 
Genes Regulated by Forskolin. Microarray analysis of MEF cultures treated or not with Fk. All cells were transduced 
with an Ascl1/RFP- encoding vector. Shown are 507 probe sets regulated in Ascl1+Fk vs Ascl1 as defined by p<0.01, 
fold change>=1.5x, and average expression in at least one group in the dataset>20 arbitrary units. See Excel file. 
 
 
 
 
 
  
Table S2. Related to Figure 5 
Genes Regulated by A(70)-Bcl-2. Table shows heatmaps of the top 60 up-regulated genes based on microarray analysis 
(Ascl1+A(70)-Bcl-2 vs Ascl1; p<0.01, fold-change≥1.45). Linear fold-changes are indicated. 
 
 Table S3. Related to Figure 5 
Analysis of Pathways Regulated by Forskolin. Enrichment analysis of canonical pathways based on the set of 1321 
probe sets differentially regulated between MEF cultures treated or not with Fk (fold change>1.3x, p<0.05, Av>20). All 
cells were transduced with an Ascl1/RFP- encoding vector. Analysis was done separately for up- and down-regulated 
probes using Ingenuity Pathway Analysis software and selected significantly enriched terms (p<0.05) are shown. 
 
 Table S4. Related to Figure 5 
Analysis of Pathways Regulated by Forskolin and A(70)-Bcl-2. Enrichment analysis of canonical pathways based on 
a set of 205 probe sets upregulated in both, MEF cultures treated with forskolin and MEF cultures expressing A(70)-Bcl-
2 (each versus control cells, paired Limma test p<0.05). All cells were transduced with an Ascl1/RFP- encoding vector. 
Analysis was done using Ingenuity Pathway Analysis software and significantly enriched terms (p<0.05) are shown. 
 
 
 
Supplemental Movies Legends 
 
Movie S1. Related to Figure 1 
Time-Lapse of the Effect of Bcl-2 During Neuronal Reprogramming 
Video example showing 150 h of astroglia-to-neuron conversion of cultures transfected with plasmids encoding 
Ascl1/RFP (cells in white, left) or Ascl1/RFP+Bcl-2 (cells in white, right; see Figure 1A and 2F for more details).  
 
Movie S2. Related to Figure 1 
DCX-GFP Reporter Expression in Ascl1- and Ascl1/Bcl-2-Mediated Reprogramming.  
Video example showing 150 h of astroglia-to-neuron conversion of cultures co-transfected with the Ascl1/RFP- or 
Ascl1/RFP+Bcl-2-encoding plasmids (RFP is shown in white, right panels) and DCX-GFP (expression of GFP is shown 
in white, left panels).  
 
Movie S3. Related to Figure 4 
Time-Lapse of the Effect of Fk During Neuronal Reprogramming. 
Video example showing neuronal conversion of astroglial cultures transfected with the plasmid encoding for Ascl1/RFP 
(cells in white) and tracked for 150 h. On the right, cells were additionally treated with Fk (20 μM) 5 h before the tracking  
time started (See Figure 1A for more details). The last frames of the movie show immunostaining for RFP (red) and β-III-
tubulin (green).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Experimental Procedures 
Transfection of Mouse Postnatal Astroglia Cultures 
For transfection DNA-liposome complexes were prepared in Optimem medium (Invitrogen) using the retroviral plasmids 
described below and Lipofectamine 2000 (Invitrogen). Astrocyte cultures were exposed to DNA-liposome complexes at a 
concentration of 0.5 µg DNA per 400 µl of Optimem medium for 4 hours and cultured after that in the differentiation 
medium as above. See (Heinrich et al., 2011) 
For survival analysis of transfected cells after immunostaining we counted the total number of RFP+ cells at 5 DPT and 
normalized by the total number of RFP+ cells counted at day 1. To quantify the ratio of neurons/initial transfected cells we 
counted the proportion of RFP+/β-III-tubulin+ cells at 5 DPT and normalized by the whole population of RFP+ cells at 1 
DPT.  
   
Cell Cultures of Pericyte-Like Cells from Adult Human Cerebral Cortex 
After removal of the meninges, tissue was dissected and dissociated mechanically. Subsequently, cells were centrifuged for 5 
min at 1000 rpm, re-suspended, and plated in a medium consisting of DMEM high glucose with GlutaMAX (Gibco), 20% 
fetal calf serum (Gibco), penicillin/streptomycin (Gibco). For reprogramming experiments cells were harvested and replated 
as described above after 2-3 weeks of expansion. See also (Karow et al., 2012) 
 
Cell Cultures of Mouse Embryonic Fibroblasts (MEFs) 
MEFs were obtained from mouse embryos at day 14 gestation. Head, spine and visceras were removed and discarded 
(Vierbuchen et al., 2010). The remaining tissue was dissociated with 0.15% of trypsin, centrifuged for 5 min at 1300 rpm, re-
suspended, and plated in a medium consisting of DMEM high glucose (3.5mM) with GlutaMAX (Gibco), 10% fetal calf 
serum (Gibco) and penicillin/streptomycin (Gibco) in 5% CO2 and normoxygenated conditions. Fibroblasts were used for 
experiments after minimum 3 passages. For reprogramming experiments cells were harvested and replated as described 
above for astrocytes. 
 
Glycolytic and Oxidative Media 
To force different metabolism during neuronal reprogramming, astrocytes were prepared and plated as previously described. 
At 24 hours after plating cells were either transfected with plasmid or infected with retroviral vectors and after further 24 
hours medium was replaced with one of the following. (1) Control medium, composed of DMEM without sodium pyruvate 
or glucose (Gibco), supplemented with penicillin/streptomycin, B27 supplement (Gibco), glucose (4,5gr/lt), sodium pyruvate 
(110mg/lt); (2) Glycolysis-only (Glyco) medium, composed of DMEM without sodium pyruvate or glucose (Gibco), 
supplemented with penicillin/streptomycin, B27 supplement (Gibco), glucose (4,5gr/lt), Oligomycin A (1µg/ml) (Gajewski et 
al., 2003). (3) Oxidative Phosporylation-only (OxPhos) medium, composed of DMEM without sodium pyruvate or glucose 
(Gibco), supplemented with penicillin/streptomycin, B27 supplement (Gibco), sodium pyruvate (110mg/lt), 2-Deoxy-D-
glucose (5mM) (Candelario et al., 2013; Gajewski et al., 2003) .  
 
Analysis of Redox State 
To evaluate general ROS we used the CellRox Green reagent from Molecular probes that acquires green fluorescence and 
nuclear localization via DNA binding upon oxidation. The procedure was accordingly with the manufacter’s specifications 
and the green reporter was finally detected by microscopy of living cells stained with DAPI.  
To detect ROS production from astrocytes in the different metabolic conditions, cells were loaded with the Dihydroethidium 
dye (DHE, life tech), a superoxide indicator that when oxidized intercalates within the cell´s DNA, staining its nucleus a 
bright fluorescent red. After 24 hours in the metabolic medium, cells were incubated for 15 minutes with DHE (30µM) at 
37°C, then washed 3 times in 1x phosphate-buffered saline (PBS), fixed with 4% PFA for 5 minutes and fluoresce was 
detected by microscopy (see below). 
For in vitro experiments the antioxidants αToc, Fk (Sigma) and/or calcitriol (Tocris) were supplemented once with the 
differentiation medium at 2 DPT/DPI in a final concentration of 0.5 µM, 20 µM and 70 µg/ µl, respectively. 
 
Plasmids and DNA Constructs 
For the expression of neurogenic transcription factors we used self-inactivating retroviral vectors containing the actin 
promoter with the cytomegalovirus early enhancer element and the splice acceptor of the rabbit beta-globin gene (pCAG) 
driving the expression of the gene of interest (flag/myc-Ascl1, flag-Neurog2, Bcl-2 or Dlx-2) linked to a fluorescent reporter 
by internal ribosomal entry site (IRES) as previously described (Heinrich et al., 2011). To follow the conversion process of 
astrocytes into neurons, we used a neuronal reporter plasmid with GFP driven by the doublecortin promoter (DCX-GFP) 
previously described (Franco et al., 2011). The mouse version of Bcl-2 cDNA was obtained from Source BioScience 
(IRAVp968H01145D; pCMV-SPORT6.1-Bcl-2) and the human cDNA version (h-Bcl-2) from addgene (Plasmid number 
8793; pMIG-Bcl-2-IRES-GFP) to generate RV-pCAG-flag/myc-Ascl1-IRES-Bcl-2, RV-pCAG-flag-Neurog2-IRES-Bcl-2 or 
RV-pCAG-Bcl-2-IRES-GFP, which encodes for both Bcl-2 and the reporter GFP. The Bcl-2 mutants A-Bcl-2 and EE-Bcl-2 
were produced by directed mutagenesis with the oligos 5’-ggctgccaggacggctcctctcaggcccctcgttg-3’ (and complemantary) and 
5’-gggacatggctgccagggaggagcctctcaggcccctcgttgcc-3’ (and complementary) respectively, to generate the vectors pCMV-
SPORT6.1-A-Bcl-2, RV-pCAG-Ascl1-IRES-A-Bcl-2 and RV-pCAG-Neurog2-IRES-A-Bcl-2 and the corresponding EE-Bcl-
2 versions. Mutations were verified by sequencing. The murine Vdr was obtained from Sino Biological (MG51106-G, Vector 
pGEM-T) and sub-cloned in the retroviral vector to generate RV-pCAG-Vdr-IRES-GFP. 
Viral vectors were produced with a vesicular stomatitis virus pseudotyping at titers of 106-9 and cells were infected about 24 
hours after splitting as described above. Cells were allowed to differentiate in 16% O2 and 9% CO2. 
 
Immunoblot Analysis 
The cultures were lysed in RIPA buffer (10 mM Na2HPO4, pH 7.2, 150 mM NaCl, 1% sodium deoxicolate, 1% Nonidet P-
40, 0.1% SDS) containing protease (Complete EDTA-free, Roche). Protein concentrations were determined with the BCA 
reagent from Interchim. Equal amounts of protein (50 μg) were diluted in Laemmli Sample buffer containing β-
mercaptoethanol (BioRad, 161-0747) and separated by polyacrylamide gel electrophoresis and transferred to polyvinylidene 
difluoride membranes (Pall; Life Sciences).  
For the detection of Prx1 the cells were previously incubated 15 min with PBS containing 100 mM N-ethylmaleimide (NEM, 
Sigma, E3876-5G) and collected in RIPA buffer also containing 100 mM NEM. In this case, samples were diluted in sample 
buffer without β-mercaptoethanol (Pierce, 84788). 
Immunodetection of proteins was performed by standard procedures (ECL Prime Western Blotting Detection Reagent, 
Amersham). 
 
Immunocytochemistry 
Cells were fixed in 4 % PFA in PBS for 10 min at room temperature (RT), washed in PBS and pretreated in 0.5% Triton X-
100 in PBS for 30 min, followed by incubation in 2% BSA and 0.5% Triton X-100 in PBS for 30 min. Primary antibodies 
were incubated on specimen overnight at 4°C in 2% BSA, 0.5% Triton X-100 in PBS. The following primary antibodies were 
used: polyclonal anti-Green Fluorescent Protein (GFP, chicken, 1:1000, Aves Labs, GFP-1020), polyclonal anti-Glial 
Fibrillary Acidic Protein (GFAP, rabbit, 1:4000, DakoCytomation, Z0334), polyclonal anti-Red Fluorescent Protein (RFP, 
rabbit, 1:500, Chemicon, AB3216, or 1:2000, Rockland 600-401-379), monoclonal anti β-III-tubulin (mouse IgG2b, 1:500, 
Sigma, T8660), monoclonal anti Map2 (mouse IgG1, 1:500, Sigma, M4403), monoclonal anti NeuN (mouse IgG, 1:300, 
Millipore, MAB377), polyclonal anti V-Glut1 (rabbit, 1:500, SYSY, 135302), polyclonal anti synaptobrevin (SV, rabbit, 
1:1000, SYSY). After washing in PBS, cells were incubated with appropriate species- or subclass-specific secondary 
antibodies conjugated to CyTM2, CyTM3, CyTM5 (1:500, Jackson ImmunoResearch), Alexa Fluor 488 (1:500, Invitrogen), 
FITC (fluorescein isothiocyanate, 1:500, Jackson ImmunoResearch), TRITC (tetramethyl rhodamine isothiocyanate, 1:500, 
Jackson ImmunoResearch) or biotin (1:500, Jackson ImmunoResearch or Vector Laboratories) for 2h in the dark at room 
temperature, followed by extensive washing in PBS. Following treatment with secondary antibodies conjugated to biotin, 
cells were subsequently incubated for 2h at room temperature with DAPI (1:1000, Sigma) and AMCA streptavidin (1:200, 
Vector Laboratories) or Alexa Fluor 647 streptavidin (1:500, Sigma, D9542) and mounted with Aqua Poly/Mount 
(Polysciences, Warrington, PA).  
 Luciferase assay 
To test the activity of the Nrf2 pathway, we used a Nrf2-responsive luciferase construct obtained from Qiagen (kit CCS-
5020). Accordingly with the described protocol, levels of Luciferase were normalized by the expression levels of a non-
responsive construct encoding Renilla.  
 
Immunohistochemistry 
Animals were anesthetized and transcardially perfused with PBS, followed by 4% PFA in PBS. Brains were post-fixed over-
night, washed twice with PBS and embedded in 4% agarose/water. Finally, 60μm-thick coronal sections were cut using a 
vibrating microtome (Leica). 
For immunohistology, sections were pre-incubated for 30 min in blocking solution (2% bovine serum albumin, 0.5% Triton 
X-100 in PBS). The following primary antibodies were diluted in blocking solution and incubated with the sections for 48 
hours at 4°C: chick anti-GFP (1:500, Aves Labs, GFP-1020), rabbit anti-RFP (1:500, Rockland, 600-401-379) or goat 
mCherry (1:250, Acris, AB0081-200), mouse anti-NeuN (1:250, Chemicon, MAB377), rat Ctip2 (1:250, Abcam, Ab18465), 
rabbit Cux1 (1:250, Santa Cruz, sc-13024), mouse Satb2 (1:250, Abcam, 51502), goat FoxP2 (1:250, Santa Cruz, sc-81069). 
After washing in PBS, secondary antibodies were diluted in blocking solution and incubated at room temperature for 2 hours. 
Such antibodies were chosen according to the primary ones and were coupled to Alexa Fluor 488 or FITC, Cy3, Alexa Fluor 
647 (Dianova). Sections were eventually counterstained with DAPI (1:500, Sigma) prior to mounting. 
 
RNA Extraction and Real Time Quantitative PCR (qRT-PCR) 
RNA was extracted using RNeasy Plus Micro Kit (Qiagen) according to manufacturer’s instructions, including removal of 
genomic DNA. RNA was retro-transcribed using SuperScriptIII Reverse Transcriptase and Random Primers (Roche). Each 
cDNA sample was diluted one to 5 and 1µl was used for each quantitative real time reaction. Real Time quantitative PCR 
(qPCR) was performed on a LightCycler480 instrument (Roche) using LightCycler Probe Master kit (Roche) and Monocolor 
Hydrolysis Probe (UPL) Probe (Roche) according to manufacturer’s instructions (20µl final volume). The expression of each 
gene was analyzed in triplicate. Data were processed with the Ct method (Livak and Schmittgen, 2001). Quantification 
was performed on 3 independent biological samples. 
 
Microarray Analysis Procedure. 
Total RNA (30 ng) was amplified using the Ovation Pico WTA System V2 in combination with the Encore Biotin Module 
(Nugen). Amplified cDNA was hybridized on Affymetrix Mouse Gene 2.0 ST arrays. Staining and scanning was done 
according to the Affymetrix expression protocol including minor modifications as suggested in the Encore Biotion protocol. 
Expression console was used for quality control and to obtain normalized RMA gene-level data. Statistical analyses were 
performed by utilizing the statistical programming environment R (Team, R. D. C., R: A language and environment for 
statistical computing. 2005) implemented in CARMAweb (Rainer et al., 2006). Genewise testing for differential expression 
was done employing the limma t-test. Sets of regulated genes were defined by p<0.01 (507 probe sets) or p<0.05 (1321 probe 
sets), including filters for fold change>=1.5x and average expression in at least one group in the dataset>20 arbitrary units. 
Heatmaps were generated with CARMAweb and pathway enrichment analyses were generated through the use of IPA 
(Ingenuity® Systems, www.ingenuity.com).  
Array data has been submitted to GEO under the accession number GEO: GSE70921 
 
Microscopy 
Immunostainings were analyzed with a LSM710 laser-scanning confocal or Axio Observer Z1 epifluorescence microscope 
(Carl Zeiss). Digital images were captured using the ZEN software (Carl Zeiss) and cell counts of all RFP/GFP 
immunoreactive cells performed with a 10X objective. 
 
Live Imaging Microscopy Analysis 
For quantifications, cells were tracked in every frame and proliferation, neuronal conversion or cell death was analyzed for 
every single cell in each movie. For quantification of proportion of dead neurons or astrocytes we counted cells dying as 
positive events and classified them as neurons or astrocytes according to their morphology described in Figure 1. Next we 
add to this value the number of surviving cells (astrocytes or neurons in each group) at the end of the tracking period. This 
result is the total population for each lineage (dead + surviving astrocytes or neurons). Finally we normalized the proportion 
of dead neurons (counted as described) to the total population of neurons (calculated as described) and the same process was 
done for astrocytes. 
 
Patch-Clamp Method 
Transfected GFP+ or RFP+ cells were recorded using the patch-clamp technique in the perforated-patch or whole-cell 
configurations.For the perforated-patch, fire-polished patch pipettes with 4-6 MΩ resistance were front-filled with 
intracellular solution containing Amphotericin B (0.33 μg /ul) and backfilled with Amphotericin-free intracellular solution (in 
mM: 4 KCl, 2 NaCl, 0.2 EGTA, 135 K-Gluc, 10 HEPES, 4 ATP, 0.5 Na-GTP; pH = 7.3, 290 mOsm). Experiments were 
performed at room temperature with constant flow (2 ml/min) of the extracellular solution (in mM: 3 KCl, 140 NaCl, 2 
CaCl2, 2 MgCl2, 10 HEPES, 5 Glucose; pH = 7.4, 305 mOsm). For the whole-cell configuration, the cells were kept in 
following extracellular solution (in mM: 125 NaCl, 3 KCl, 1.25 NaH2PO4, 25 NaHCO3, 25 D-Glucose, 0.4 Ascorbic acid, 2 
CaCl2, 2 MgCl2; pH = 7.4, 310-330 mOsm) oxygenated by 95% O2/5% CO2 with constant fluid flow (2ml/min) at room 
temperature. The cells were recorded at 5 days post-transfection in the whole-cell configuration (4-6 MΩ electrodes) with the 
following intracellular solution (in mM: 135 K-Gluconat, 4 KCl, 2 NaCl, 10 HEPES, 0.2 EGTA, 4 ATP, 0.5 NaGTP, 10 
Phospho-Kreatin; pH = 7.3, 290-300 mOsm). The passive membrane properties were recorded using the membrane test 
paradigm of the pClamp software (Molecular Devices, Sunnyvale, CA, USA). In the voltage-clamp mode, a series of 10 mV 
rectangular pulse increments (50 ms long) ranging from -120 mV to +100 mV was used. Data were sampled at 10-30-μs 
intervals and low-pass filtered at 2 kHz using the Axopatch 200B 4-pole Bessel filter (Molecular Devices). Leak currents 
were subtracted after the test pulse using five repeated 10 mV negative pulses from a holding potential of −120 mV. The 
current-voltage relation expressed the steady-state whole-cell current (at 40 ms of the rectangular pulse) as a function of the 
voltage command. In the current clamp, 1 second current injections of 10 pA increments were applied from 0 to 150 pA. All 
recorded cells were photographed both in the brightfield and the fluorescence using a CCD digital camera (Orca-D2, 
Hamamatsu, Herrsching, Germany). 
 
Statistics 
All error bars in this work indicate ±SD. Statistical analyses were performed with GraphPad Prism 4 software by using t test 
or ANOVA with different post-hoc tests (Tukey’s, Holm-Sidak’s or Dunnett’s). All the transfected cells from 3 coverslips 
were counted for each experiment with at least 3 independent experimental batches. Retroviral vector-transduced cells were 
quantified from five randomly chosen 10x fields in 3 different wells for each experiment in at least 3 independent 
experiments.  
For in vivo experiments, pictures of the injected area were acquired with a confocal microscope (Zeiss) using 40x 
magnification. Cells infected by either one virus or both were quantified according to NeuN immunoreactivity, in animals 
treated and untreated with calcitriol or α-Tocotrienol, with the open-source software Fiji (http://fiji.sc/Fiji). The data were 
tested for significance using t test or two-way ANOVA analysis (no repeated measurements) with Tukey’s correction for 
multiple comparisons (Prism 6, GraphPad). Asterisks in the plot represent multiplicity adjusted P-values. 
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